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ABSTRACT 
Reliable detection of intrapartum fetal acidosis is crucial for preventing morbidity. 
Hypoxia-related changes of fetal heart rate variability (FHRV) are controlled by the 
autonomic nervous system. Subtle changes in FHRV that cannot be identified by 
inspection can be detected and quantified by power sp ctral analysis. Sympathetic 
activity relates to low-frequency FHRV and parasympathetic activity to both low- and 
high-frequency FHRV.  
The aim was to study whether intra partum fetal acidosis can be detected by 
analyzing spectral powers of FHRV, and whether spectral powers associate with 
hypoxia-induced changes in the fetal electrocardiogam and with the pH of fetal blood 
samples taken intrapartum. The FHRV of 817 R-R interval recordings, collected as a 
part of European multicenter studies, were analyzed. Acidosis was defined as cord pH ≤ 
7.05 or scalp pH ≤ 7.20, and metabolic acidosis as cord pH ≤ 7.05 and base deficit ≥ 12 
mmol/l. 
Intrapartum hypoxia increased the spectral powers of FHRV. As fetal acidosis 
deepened, FHRV decreased: fetuses with significant birth acidosis had, after an initial 
increase, a drop in spectral powers near delivery, suggesting a breakdown of fetal 
compensation. Furthermore, a change in excess of 30% of the low-to-high frequency 
ratio of FHRV was associated with fetal metabolic acidosis. 
The results suggest that a decrease in the spectral powers of FHRV signals concern 
for fetal wellbeing. A single measure alone cannot be used to reveal fetal hypoxia since 
the spectral powers vary widely intra-individually. With technical developments, 
continuous assessment of intra-individual changes in spectral powers of FHRV might 
aid in the detection of fetal compromise due to hypoxia. 
 
 






Sikiön synnytyksenaikainen hapenpuute ja sikiön sykevaihtelun 
tehospektianalyysi 
Synnytys- ja naistentautioppi ja Sydäntutkimuskeskus, Turun yliopisto 
Annales Universitatis Turkuensis, Medica-Odontologica,  
Uniprint, Oulu, 2012 
TIIVISTELMÄ  
Sikiön synnytyksenaikaisen hapenpuutteen luotettava unnistaminen on tärkeää, jotta 
voidaan estää vastasyntyneen sairastavuutta. Synnytyksenaikainen hapenpuute aiheuttaa 
autonomisen hermoston välityksellä muutoksia sekä sikiön syketasoon että 
sykevaihteluun. Näitä sikiön sykevaihtelun, osin silmälle näkymättömiä muutoksia 
voidaan tutkia tehospektrianalyysin avulla. Sympaattinen aktivaatio näkyy 
sykevaihtelun spektrin matalataajuuskaistoissa ja parasympaattinen aktivaatio sekä 
matala- että korkeataajuuskaistoissa. 
Tutkimuksien tavoitteena oli selvittää miten 817 sikiön sykevaihtelun spektrikaistat 
muuttuvat synnytyksen aikana, miten eri spektrikaistat korreloivat synnytyksen aikana 
sikiön päänahasta mitattuun pH arvoon, ja miten sykevaihtelun muutokset heijastuvat 
syntymän jälkeiseen happo-emästaseeseen. Tutkimuksessa selvitettiin myös, miten 
sykevaihtelun spektrikaistojen muutos sikiö-EKG:n ST-hälytyksen yhteydessä korreloi 
sikiön metaboliseen asidoosiin (syntymä-pH ≤ 7,05 ja emäsvaje (BD) ≥ 12 mmol/l). 
Sykevaihtelun spektrianalyysi osoitti selkeitä eroja hapenpuutteisen ja terveen sikiön 
välisessä synnytyksenaikaisessa sykevaihtelussa. Lievässä hapenpuutteessa spektritehot 
ensin nousevat, mutta hapenpuutteen vaikeutuessa ja asidoosin ilmaantuessa 
sykevaihtelun spektritehot laskevat. Tutkimus osoitti myös, että synnytyksen kuluessa 
sykevaihtelu muuttuu selvästi sikiö-EKG:n ST-muutosten yhteydessä niillä sikiöillä, 
jotka eivät pysty mukautumaan hapenpuutteeseen synnytyksen aikana vaan joille 
kehittyy perinataalivaiheessa metabolinen asidoosi.  
Tulokset viittaavat siihen, että sikiön sykevaihtelun spektritehojen pieneneminen 
synnytyksen aikana varoittaa sikiön kompensaatiokyvyn heikkenemisestä. Koska 
yksilöllinen spektrikaistojen vaihtelu on suurta, ei yksittäisellä mittauksella voida 
identifioida hapenpuutteista sikiötä, mutta sikiön sykevaihtelun spektritehojen 
muutosten seuraaminen synnytyksen kuluessa voisi auttaa hapenpuutteisen sikiön 
tunnistamisessa. 
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Oxygen supply from the mother to her fetus may be endangered during delivery. This 
may, in the worst case, lead to fetal cerebral damage or death. The incidence of cerebral 
palsy varies from 1.6 to 2.2 per 1000 (Lie et al. 2010, Hagberg et al. 1993, 
Himmelmann et al. 2010, Pierrat et al. 2005), and intrapartum oxygen deficiency is the 
probable cause of 6 - 13% of these (Himmelmann et al. 2010, Pierrat et al. 2005, 
Pschirrer et al. 2000, Gilbert et al. 2010). Intrapartum acidosis may also lead to 
meconium aspiration and metabolic disturbances and, later in life, to cognitive 
dysfunctions (Hutter et al. 2010). 
To prevent morbidity, early detection of fetal acidosis is crucial. The most widely 
used method for monitoring fetal well-being during delivery is cardiotocography 
(CTG), but CTG is non-specific with regard to identification of fetal acidosis.  Since 
visual interpretation of CTG is subjective, there is a high inter- and intraobserver 
variability in how nonreassuring fetal heart rate (FHR) tracings are viewed by clinicians 
(Chauhan et al. 2008). Continuous CTG monitoring may also lead to an increased 
numbers of cesarean sections and instrumental vaginal deliveries (Thacker et al. 2003). 
Fetal scalp blood sampling (FBS) is the golden standard for identification of 
intrapartum fetal acidosis, and is used alongside CTG. However, fetal blood sampling 
needs often to be repeated, and is thus time-consumi g and inconvenient for the 
parturient. Furthermore, it is not free of complications, and fetal scalp infections and 
hemorrhages may ensue (Sabir et al. 2010). 
Recently, ST analysis of the fetal electrocardiogram (ECG) (STAN®) has been used 
to assess fetal wellbeing during delivery. Compared to FBS, ST analysis yields 
continuous information and is more convenient for the parturient. However, STAN® is 
also dependent on subjective interpretation of the CTG. More objective and detailed 
information on fetal responses to hypoxia are clearly needed. 
During oxygen deficiency, the autonomic nervous system (ANS) is activated, and 
this causes changes in the control of FHR (Pulgar et al. 2009). In an experimental 
animal study on a sheep, occlusion of umbilical cord caused a decrease in FHR and an 
increase in short-term fetal heart rate variability (FHRV) in fetuses, together with a 
slight decrease in pH. Increased FHRV is thought to be an important sign of adequate 
circulatory adaptation in the compromised fetus (Frasch et al. 2009). A frequency-
specific assessment of FHRV by power spectral analysis may be used to monitor 
features of fetal autonomic cardiac control (Siimes et al. 1990, Sibony et al. 1994, van 
Ravenswaaij-Arts et al. 1993). Spectral analysis provides a tool for quantifying small 
changes in FHRV that remain undetected if heart rate tracings are only interpreted 
visually. In human fetuses, the value of spectral analysis for detecting changes in 
cardiac control is poorly known, and there have been no studies on the clinical 
usefulness of this technique. The aim of this thesis was to examine if spectral analysis 
of FHRV of term fetuses is useful in detecting intrapartum hypoxia and acidosis at 
birth. 
Review of the literature 
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2. REVIEW OF THE LITERATURE 
2.1 Fetal hypoxia during delivery 
2.1.1 The hypoxemic cascade 
A fetus may be exposed to different degrees of oxygen deficiency during labor. 
Acidemia refers to a high hydrogen ion concentration in the blood. Intrapartum hypoxia 
may lead to acidosis, with a high hydrogen ion concentration in the fetal tissues 
(Bobrow et al. 1999). 
Intrapartum hypoxia can be divided into three phases according to how serious 
oxygen deficiency is. The first and mildest phase is hypoxemia, when oxygen saturation 
in blood is decreased, and the fetus becomes hyperca nic. At this stage, cell and organ 
functions remain intact. In the second phase, hypoxia, oxygen deficiency affects the 
peripheral tissues and acidemia develops, while central organs remain well-oxygenated. 
Finally, if oxygen deficiency is prolonged, the fetus switches to anaerobic metabolism for 
its energy. This results in metabolic acidosis of the tissues, affects the central organs and 
leads to organ dysfunction. This phase is called fetal asphyxia (Peeters et al. 1979, Low 
1997). 
Intrapartum fetal acidemia can be estimated by measuring the pH or lactate from a 
FBS. Scalp pH-values between 7.20 and 7.25 have been considered borderline, as a 
scalp blood pH-value of 7.20 is the lower limit (-2 SD) of the reference range. These 
guidelines are the golden standard (Bretscher et al. 1967). For lactate measurements, 
every measuring device needs its own reference values (Nordström 2004). Scalp blood 
lactate values < 4.2 mmol/l have been considered normal, although values < 5.4 mmol/l 
have also been related to normal fetal outcome (Kruger et al. 1999, Heinis et al. 2011).   
At birth, fetal hypoxia and metabolic acidosis can be evaluated from umbilical cord 
blood samples. A cord artery pH-value ≤ 7.05 has been used as a marker of significant 
acidosis (Amer-Wåhlin et al. 2002, Goldaber et al. 1991, Norén et al. 2003). However, 
it seems that metabolic acidosis is more closely associated with adverse fetal outcomes 
(Low et al. 1994). Algorithms based on measured pH and Pco2 (partial pressure of 
carbon dioxide) are used for calculating the umbilical artery base deficit (BD) (Wiberg 
et al. 2006). A low pH with normal BD in a cord blood sample reflects acute respiratory 
acidosis, and if the BD is increased hypoxia has been more prolonged and anaerobic 
metabolism has ensued (Figure 1). A BD value < 8 mmol/l is considered normal, while 
BD values 8 - 12 mmol/l are associated with minor neonatal complications. A BD value 
>12 mmol/l marks for prolonged hypoxia and metabolic acidosis, which predisposes the 
infant to moderate or severe asphyxic complications (Low et al. 1997, Andres et al. 
1999). 
There are no absolutely specified pH criteria or other criteria that distinguish 
neonates who will have injury due to intrapartum acidosis from neonates who will not. 
Brain damage was induced in ovine fetal brain by umbilical cord occlusion (Ikeda et al. 
1998) and it was found that severity of brain injury correlated with the duration of 
hypotension, but not with the duration of bradycardi  or the severity of acidosis or 
Review of the literature 
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hypoxia. This suggests that fetal vulnerability depends on individual reserves used to 
meet challenging hypoxic situations during delivery.  
 
Figure 1. Development of fetal acidosis. 
2.1.2 Mechanisms of fetal hypoxia 
In humans, decreased perfusion through the umbilical vessels or the placenta is the 
most common cause for oxygen loss to the fetus (King et al. 2000). Acute fetal hypoxia 
intra partum may occur for several reasons: compression of the umbilical cord, 
diminished uterine blood flow and gas-exchange, matern l hypotension or maternal 
oxygen deficit, abruption of the placenta, or abnormal uterine contractions. Abrupt 
hypoxia due to abruption of the placenta, uterine rupture or umbilical cord prolapse is a 
dramatic event, usually neither predictable nor preventable but usually easily detected 
as prolonged bradycardia in the CTG (Westgate et al. 1999b). Acute maternal 
hypotension or oxygen deficiency is presumably alsopromptly noticed by caregivers, if 
it causes fetal hypoxia.  
During the course of normal labor, there the placental gas-exchange is intermittently 
reduced. Hyperactive uterine contractility, often induced by oxytocin, is an important 
Reduced oxygen saturation 










Metabolic      
acidosis 
Decreased pH 
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risk factor for acidemia at birth (Jonsson et al. 2008). During the contractions, the 
umbilical cord may be compressed in such a way thatblood flow to the fetus is 
restricted or even stopped. This causes fetal hypertension and a rapid baroreceptor 
reflex. The fetal reaction to this transient oxygen deficiency is often seen as a sharp, 
short drop of FHR on the CTG during a contraction (King et al. 2000). However, the 
reasons for CTG changes usually remain unclear.  
The fetus may have chronic hypoxia already during (early) pregnancy due to 
placental insufficiency or limited maternal oxygen uptake due to some maternal 
disease, e.g. congenital heart disease. Chronic hypoxia may impair the ability of the 
fetus to cope with the stress of labor (Hutter et al. 2010, Westgate et al. 1999b, de Haan 
et al. 2006).  
2.1.3 Fetal defense mechanisms against acidosis  
The development of fetal acidosis, and the perinatal outcome, depends on three factors: 
1) initial status of the fetus, 2) duration of hypoxic stress intra partum, and 3) intensity 
of the stress (Fleischer et al. 1982).  
In experimental animal studies, hypoxia has been induced by reducing the inspired 
partial pressure of oxygen to the mother, or by reducing uterine or umbilical blood flow 
(Jensen et al. 1999). These studies have shown that chronic hypoxia causes fetal growth 
retardation, increased catecholamine levels, and redist ibution of blood flow to the vital 
organs. In these chronically hypoxic fetuses, there is no physiological increase in 
FHRV following maturation with advancing gestational age (GA). The FHR and blood 
pressure increase initially and return to baseline evel with time. Constant chronic 
hypoxia without acidosis causes changes neither the fe al body movements nor the fetal 
breathing movements (Murotsuki et al. 1997, Gardner et al. 2002, Salihagic-Kadic et 
al. 2006, Martin 2008, Bocking 2003). A simplified table of hypoxia-related changes in 
animal experiments is presented in Table 1. 
As a consequence of chronic hypoxia, the fetus fails to achieve its genetically 
determined growth potential (Hutter et al. 2010). Chronically compromised fetuses are 
not only more susceptible to peripartum hypoxia, but are also more sensitive to 
asphyxic damage, probably due to lower carbohydrate and other nutritional stores 
(Parer 1998).  
When a chronically hypoxic fetus is predisposed to acute hypoxia, the blood 
pressure rises and the redistribution of blood flow is attenuated. When the acute 
hypoxia is over, fetal bradycardia returns to the normal pulse rate faster than in control 
fetuses not chronically hypoxic. Catecholamine levels are increased and rise even 
further. Thus, adverse intrauterine conditions blunt the fetal responses to subsequent 
episodes of acute hypoxia (Gardner et al. 2002). When chronically hypoxic fetuses 
become acidemic, FHRV gradually decreases after an initial rise. FHR is also reduced 
with severe acidosis (Ikeda et al. 1998, Dalton et al. 1977). 
Acute hypoxia induces fetal bradycardia and increases both the heart rate variability 
and the blood pressure of the fetus. With prolonged hypoxia, FHRV decreases, and 
catecholamines are released. The catecholamine levels ris  in fetuses who have reduced 
pH-values in scalp blood samples and umbilical cord blood samples. As a 
Review of the literature 
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compensatory mechanism to the decreased oxygen levels, fetal blood flow is 
redistributed in favor of the vital organs (Jensen et al. 1999, Gardner et al. 2002, 
Martin 2008, Dalton et al. 1977, Bennet et al. 2009, Thakor et al. 2009, Wassink et al. 
2007). The compensating responses of the fetus to different degrees of oxygen 
deficiency are presented in Table 2.  
It is speculated that acute acidemia might sensitize the fetal responses to oxygen 
deficiency and cause an increase in both vagal and sympathetic autonomic outflow. In 
an experimental animal study labor-like progressing hypoxia was induced in lamb 
fetuses by one-minute repeated cord occlusions. This was followed by a five-min 
recovery period. In this setting, FHRV did not change significantly during the four-hour 
study period; fetal acidosis enhanced, however, the response markedly. When the 
recovery period was shortened to 2.5 minutes, the fetuses developed metabolic acidosis 
(pH = 6.92; BD = 17 mmol/l) at the end of the study. The FHRV of these fetuses 
increased transiently at first, but toward the end of the study period, the FHRV 
decreased and there was a rapid overshoot and instability of FHR after the occlusions.  
Still, a couple of fetuses (which had lower lactate levels) had increased FHRV at the 
end of the study. Hence, the individual reactions to imilarly induced hypoxia seem to 
differ, probably due to different initial compensating reserves (Thakor et al. 2009, 
Westgate et al. 1999a). 
A fetus responds to hypoxia by a so-called brain-sparing effect. This means 
redistribution of blood flow in favor of vital organs such as the brain, heart and adrenals 
at the expense of peripheral organs (Jensen et al. 1999). The fetus reduces its oxygen 
consumption by reducing its intrauterine movements and breathing movements. 
However, if hypoxia develops gradually, the fetus will show adaptation and return to a 
normal activity level after several hours (Koos et al. 1988, Bocking et al. 1988). The 
adaptation processes activated by the changed circumstances are controlled by the 
ANS. When uterine blood flow in a lamb was experimentally restricted long enough to 
cause fetal acidosis (mean pH = 7.0), agonal, preterminal FHR patterns emerged (mean 
heart rate 81 bpm; mean pH = 6.86) and the blood flow to the vital organs, which had 
increased initially, ultimately decreased profoundly (Block et al. 1990). Thus, although 
the lamb fetus is able to modify its blood circulation even during severe hypoxia, 
prolonged anoxia leads to breakdown of the compensatio  mechanisms.  
The initial reserves of the fetus to withstand variable hypoxic conditions during 
delivery cannot be measured and the individual´s compensatory capacity is tested 
during intrapartum stress. 
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Table 1.  Fetal responses to hypoxia. FHR = fetal heart rate; FHRV = fetal heart rat 
variability; BP = fetal blood pressure; ↑,→= first increase, then return to 
baseline; ↑,↓ = first increase, then decrease; ↔ = no change; ↑ = increase; ↓ = 
decrease 
 
Table 2.  Fetal response to oxygen deficiency. 
 

















↓ ↑,↓ ↑   yes ↑↑ 
Acute 




↓ ↓ ↑,↓     
HYPOXEMIA HYPOXIA ASPHYXIA 
• more effective oxygen 
uptake, increase in 
hemoglobin level 
• reduced intrauterine 
movements 
• decreased growth rate 
• maintained energy balance 
• surge of stress hormones 
• redistribution of blood flow 
• switch to anaerobic 
metabolism in peripheral 
tissues 
• maintained energy balance 
• alarm reaction, all 
compensating systems in use 
• switch to anaerobic 
metabolism also in the central 
organs 
• heart failure ensues 
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2.2 Autonomic control of fetal cardiac function 
2.2.1 Autonomic control of fetal heart rate 
The ANS coordinates the cardiovascular system and adjusts functions to appropriate 
levels in stress situations. The heart is under the control of both the sympathetic and the 
parasympathetic nervous systems. The sympathetic nervous system has cardio-
acceleratory effects, whereas the parasympathetic system has cardio-inhibitory effects 
(Table 3). Besides these neural control systems, there are also non-neural, humoral 
transmitters that augment the effect of neural transmitters. Catecholamines 
(noradrenaline, adrenaline, dopamine) are released from the adrenal medulla to 
augment the effect of the sympathetic nervous system, especially in stress situations. 
The parasympathetic nervous system influences the heart via the vagal nerve, which 
conducts impulses from the medulla oblongata in the central nervous system to the 
sino-atrial node in the fetal heart. The sympathetic nervous system has nerve fibers that 
terminate throughout the muscle of heart (King et al. 2000). Although there are 
significant non-neural influences, it appears that a large proportion of FHRV may be 
explained by centrally mediated fluctuations of theANS (Oppenheimer et al. 1994). 
Further, an important determinant of FHRV is the actu l FHR. Low FHRV associates 
with higher FHR as high FHRV appears with lower FHR (Lange et al. 2005). 
The role of the sympathetic and parasympathetic limbs of the ANS on the 
modulation of FHRV has been studied mostly in animal odels under pharmacological 
manipulation. In ovine fetuses, parasympathetic (vagal) blockade with atropine reduces 
FHRV as FHR increases. Sympathetic blockade with propranolol does not change 
FHRV, although FHR decreases. When both limbs of the ANS are blocked, FHR 
increases and FHRV decreases dramatically, implying that ANS is directly responsible 
for a large part of FHRV. Still, the influence of non-neural systems persists, since some 
variability does remain after double blockade of the ANS (Dalton et al. 1983). The 
findings in human fetuses are consistent with the experimental studies. Blocking the 
sympathetic nervous system by an injection of propranolol under the skin of the fetal 
scalp lowers FHR, while blocking the parasympathetic nervous system with atropine 
increases FHR (Renou et al. 1969).  
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Table 3.  Differences in the activation of the fetal autonomic nervous system. 
2.2.2 Maturation of autonomic cardiac control and heart-rate 
variability 
The gestational age affects the control of ANS. Thesympathetic control of the heart 
begins early in gestation. The parasympathetic system matures later and has only little 
effect on FHR prior to term gestation (Walker et al. 1978). Experimental studies on 
ovine fetuses have identified functional cardiac adrenergic (sympathetic) control as 
early as on the 60th day of gestation (gestation averages 145 days), whereas preterm 
fetuses showed only little parasympathetic control of the heart. The effect of the 
parasympathetic control increases toward term, during the last third of gestation, but 
parasympathetic blockade with atropine in term fetus s raises FHR only with 10%. This 
observation suggests also that there is progressive maturation of parasympathetic 
control in late gestation, which probably extends through the early neonatal period 
(Walker et al. 1978, Nuwayhid et al. 1975). Therefore, the sympathetic 
cardioaccelerating tone predominates over the parasympathetic cardioinhibitory tone 
during intrauterine life (Assali et al. 1977). As the vagal activity increases as of the 
second trimester of pregnancy, FHR gradually decreases towards term (King et al. 
2000, Walker et al. 1978, Wakatsuki et al. 1992). The FHRV increases with advancing 
GA (Wheeler et al. 1978, Ribbert et al. 1991a, Park et al. 2001).  
As there is maturation of the neural control of the heart, there is maturation of non-
neural cardiac control. As the fetus matures, it may become more responsive to 
increased humoral stimuli (Nuwayhid et al. 1975). When lamb fetuses were exposed to 
acute hypoxia caused by complete occlusion of the maternal abdominal aorta for 60 
seconds, there was a higher increase in noradrenalin  levels in mature fetuses than 
immature fetuses. In mature fetuses also the T/QRS ratio in the fetal ECG peaked 
higher due to hypoxia and recovery rates were slower than in immature fetuses 
(Widmark et al. 1989). These different cardiac responses are mainly related to the level 
of fetal maturation, and may be caused by changes in the ANS or by organ hypoxic 
reactivity. The increase in catecholamine levels after only short hypoxic periods 
SYMPATHETIC ACTIVATION PARASYMPATHETIC ACTIVATION 
• slower response 
•  stress hormones  
•  increase cardiac contractility  
• increase in heart rate 
• blockade with propranolol 
• fast response 
• vagal nerve 
• decrease in heart rate 
• blockade with atropine 
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emphasizes the importance of the sympatheticoadrenal system for the maintenance of 
fetal hemodynamics during hypoxia (Widmark et al. 1989). 
2.2.3 Intrapartum factors affecting fetal autonomic cardiac control 
and heart rate variability 
2.2.3.1 Fetal factors 
FHR and FHRV are affected by fetal intrauterine movements and breathing. 
Accelerations in FHR are mostly associated with fetal movements, and can occur with 
or without a contraction (Dawes et al. 1981, Sadovsky et al. 1984). Growth-retarded 
fetuses have lower increase in FHRV as a response to intrauterine movements than 
control fetuses (Breborowicz et al. 1988), which may be due to diminished reserves of 
cardiovascular control in fetuses with growth retardation. 
In mature fetuses before labour, fetal breathing movements are related to reduced 
FHR and increased beat-to-beat FHRV (Dawes et al. 1981, Divon et al. 1985). During 
labor, fetal breathing decreases and the fetus makes breathing movements only during 
about 1% of the time (Boylan et al. 1980). The intrauterine movements of the fetus are 
also reduced during labor, especially if hypoxia is present (Natale et al. 1981, Kozuma 
et al. 1997).Thus, breathing movements and other movements are unlikely to interfere 
substantially with the interpretation of FHRV during delivery.  
2.2.3.2 Hypoxia 
Hypoxia induces changes in FHR and FHRV which are controlled by the ANS, along 
with chemoreceptors, baroreceptors, increased secretion of catecholamines and higher 
cortical functions in the brain (King et al. 2000, Rosén et al. 1984, Jones et al. 1975). 
The importance of adequately functioning cardiovascular control systems has been 
shown in a study with ovine fetuses whose both carotid chemoreflexes and release of 
catecholamines were blocked. The survival of these fetuses during hypoxia was 
substantially reduced (Giussani et al. 1993). 
Hypoxia increases the activity in parasympathetic effer nt vagal fibers to the heart 
and induces bradycardia. This is a marker of an adequat  compensating mechanism, as 
the energy demand on the heart decreases and helps t  fetus to cope with hypoxia. 
However, after a hypoxic episode, increased sympathetic activity may rapidly increase 
FHR and FHRV (overshoot acceleration) (Bennet et al. 2009). Fetuses which are 
stressed at the outset and have increased catecholamine levels might not be able to 
compensate for acute hypoxic events, as implied by the finding that the FHR of such 
fetuses returned to control values after an initial period of bradycardia. These fetuses 
had more marked acidosis compared to fetuses with sustained bradycardia during the 
whole (one-hour) study period (Jones et al. 1975, Giussani et al. 1993).  
A reduction in FHRV in the presence of bradycardia appears to be a rather late sign 
of severe acidosis (van Ravenswaaij-Arts et al. 1993, Ribbert et al. 1991b) and is 
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associated with reduced cerebral oxygen consumption and poor fetal outcome (Williams 
et al. 2002, Field et al. 1991). Overall, the amount and direction of hypoxia-induced 
changes in FHR and FHRV depend on the initial statu of the fetus, and also on depth 
and duration of the hypoxic episode. 
2.2.3.3 Contractions 
Uterine contractions affect FHR by temporarily reducing or stopping cord blood flow, 
increasing fetal blood pressure and thus affecting ANS. During contractions, FHR 
increases or decreases, depending on the fetal status. In a healthy, non-stressed fetus, 
FHR may remain unchanged during contractions. A marked increase in FHR is noted 
during contractions in the presence of fetal body movements. After a contraction, 
FHRV returns to the baseline level. This happens regardless of fetal movements. An 
increase in FHRV during contractions may be due to mild hypoxia or increased vagal 
tone (Zimmer et al. 1987, Zimmer et al. 1988, Divon et al. 1984, Romano et al. 2006). 
Increased FHR and FHRV during a contraction is a sign of adequate fetal reactivity to 
uterine pressure stimulus and marks fetal wellbeing (Divon et al. 1984).  
Compared to non-laboring women, FHRV is overall greater during labor in fetuses 
with a reassuring CTG pattern (Agrawal et al. 2003). In the course of labor, the long-
term variation of FHR increases (Pello et al. 1991), although with more frequent, 
longer, and intense contractions, FHRV may decrease (Zimmer et al. 1998); this may be 
due to an aggravation of hypoxemia with more intense contractions.  
2.2.3.4 Labor analgesia 
Labor analgesia may affect the FHR. Paracervical angesia is safe and affects neither 
the FHR nor fetal oxygenation (Kaita et al. 2000). In contrast, intrathecal or epidural 
analgesia may affect the FHR, but any changes are minimal as long as the mother does 
not have hypotension or uterine hypertonia. Effectiv  labor analgesia decreases 
adrenaline levels in the painful parturient. As adrenaline has a tocolytic effect, rapid 
labor pain relief might increase uterine activity, which would be beneficial for 
parturients with slowly progressing labor. Intrathecal analgesia may cause uterine 
hyperreactivity, especially if the parturient also receives oxytocin (Palmer et al. 1999, 
Capogna 2001).  
In a study of 200 patients on epidural or intrathecal analgesia, 22 had significant 
FHR changes. In four patients, the changes suggested improved fetal status. Eighteen 
patients had FHR abnormalities (decelerations or bradycardia), but none required urgent 
delivery because of these changes. Nonetheless, the incid nce of FHR changes was low 
(6% in the epidural group and 12% in the intrathecal group), and all changes were 
transient and resolved within 30 minutes (Palmer et al. 1999). Overall, labor analgesia 
decreases maternal stress and circulating catecholamine levels, corrects possible 
maternal metabolic acidosis if present, and may thus improve uteroplacental perfusion. 
Epidural analgesia improves the fetal acid-base balance at birth (Reynolds 2011). 
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2.3 Intrapartum fetal monitoring 
2.3.1 Cardiotocography 
Cardiotocography records FHR changes and their temporal relationship to uterine 
contractions. The aim of intrapartum monitoring is to identify fetuses that are becoming 
hypoxic, and to prevent an adverse outcome. A normal FHR tracing during labor 
predicts a well-oxygenated neonate with a normal acid-base balance. However, CTG 
has several limitations: the positive predictive value of abnormal intrapartum FHR 
patterns for fetal acidemia is only around 30 %, and continuous CTG monitoring may 
increase unnecessary operative interventions (Spencer 1993, Alfirevic et al. 2006). The 
FHR tracings are interpreted visually, i.e. subjectiv ly, which leads to high 
interobserver variability, especially of nonreassuring tracings. There is a lack of 
agreement on how to classify most abnormal features of the FHR tracing (Chauhan et 
al. 2008), while the agreement among is better concerning normal tracings (kappa value 
= 0.86, total agreement gives a kappa value = 1.0) (Blix et al. 2003).  
Continuous electronic fetal monitoring has been criticized for an inability to 
decrease fetal mortality and cerebral palsy and for increasing the incidence of 
unnecessary operative deliveries. Nevertheless, the technique is still widely used as a 
routine method for fetal surveillance intra partum: in some countries at least 85 % of 
births are monitored with CTG (Bailey 2009). 
Automatic computerized analysis of the FHR pattern during labor may be a method 
for improving the accuracy and consistency of detecting specific FHR patterns (Dawes 
et al. 1994, Parer et al. 2010). It provides a precise and reproducible algorithm-based 
approach to FHR analysis. Different FHR variables (baseline, variability, accelerations 
and decelerations), together with the incidence of fetal movements, can be measured. 
Long-term FHRV is defined as the mean of a one-minute range of pulse intervals and 
short-term FHRV as the mean of successive epochal (1/16 min; 3,75 s) pulse interval 
differences. The results of the analysis are given on-line (Dawes et al. 1994). Different 
analysis devices measure different variables. FHR tracings have been successfully used 
for computerized analysis of FHRV before labor (Dawes et al. 1992). Unfortunately, 
this analysis has not proved helpful during labor, since there has been no correlation 
between FHR variables and fetal acidemia at birth. Overall, the predictive value of 
various features of FHR tracings with regard to fetal acidemia is poor (Agrawal et al. 
2003, Pello et al. 1991, Parer et al. 2006, Schiermier et al. 2008). Altogether, the FHR 
pattern offers only a partial picture of the fetal status, and new methods are needed to 
identify fetuses at risk for acidosis.   
2.3.2 Fetal scalp blood pH 
Fetal scalp blood sampling is used as a golden standard to identify intrapartum fetal 
hypoxia. CTG can be used for screening tool; FBS is taken under certain conditions 
when the CTG is nonreassuring (NICE Clinical Guideline 2007 ). The pH-value falls, 
when the acidity of the body fluids increases as a consequence of accumulation of lactic 
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acid due to metabolic acidosis (Parer 1980). Since acidosis is a key feature of fetal 
asphyxia, a decreasing pH-value indicates fetal distres  and a risk of permanent tissue 
damage. A low pH and accumulation of lactic acid are due to oxygen and caloric deficit 
in tissues and are related to perinatal brain damage (Fleischer et al. 1982). 
There are only few contraindications to FBS. They are: certain maternal blood-borne 
infections (hepatitis, human immunodeficiency virus, active maternal herpes simplex), 
fetal bleeding disorder, and fetal prematurity (< 34 weeks of gestation) (Heazell et al. 
2011). 
FBS gives only momentary information of fetal wellbing (concerning 
oxygenation), and needs often to be taken repeatedly.  FBS is time-consuming and 
inconvenient to the parturient and may lead to complications, e.g. fetal scalp infection 
and hemorrhage. The incidence of complications ranges from 0.4 to 6 % Most 
complications due to FBS are insignificant, although exceptional cases of neonatal 
death due to bleeding from the incision wound have be n reported (Sabir et al. 2010, 
Schaap et al. 2011).  There is no correlation between fetal scalp pH and neonatal 
outcome (NICE Clinical Guideline 2007 ). There are many confounding factors, e.g. air 
or amniotic fluid contamination or congestion of the fetal scalp which may affect the 
result. In prolonged labor, maternal acidosis may develop: as acid equivalents cross the 
placenta fetal capillary pH is reduced. All these matters should be kept in mind when 
using FBS to interpret fetal wellbeing during labor (Mahendru et al. 2011). In a 
Cochrane Review (Alfirevic Z et al. 2008), the use of FBS was questioned: There was 
no evidence that the incidence of caesarean section rate was greater in trials where FBS 
was not available. Moreover, access to FBS data did not appear to influence the 
occurrence of neonatal seizures nor any other specified outcome. 
2.3.3 STAN® 
Fetal hypoxia alters the shape of the ECG tracings and technical systems to monitor the 
ECG of the fetus have been developed (Neilson 2006). The ST waveform of the fetal 
ECG provides continuous information on the metabolic status of the heart and the 
ability of the fetal heart muscle to respond to decreased oxygenation caused by the 
stress of labor. Fetal ECG is recorded during labor with a spiral electrode attached to 
the scalp of the fetus. The STAN® (ST ANalysis; Neoventa Medical, Mölndal, Sweden) 
monitor analyses the ST segment of fetal ECG as an adjunct to a standard CTG. The 
ratio between the amplitudes of the T waves and QRS complexes (T/QRS) is 
quantified. An increase in the height of the T wave occurs in hypoxia when the energy 
balance becomes negative and glycogen reserves in the heart are used anaerobically for 
extra energy. A change in the T/QRS ratio compared to an earlier T/QRS ratio is called 
an ST event in the STAN® nomenclature. The significance of this ST event is evaluated 
according to STAN® clinical guidelines (Amer-Wåhlin et al. 2011). The indications for 
using STAN® are: need for more detailed fetal surveillance (high-risk pregnancies), 
possible or clearly abnormal external CTG, induced or oxytocin-enhanced labor, 
meconium-stained amniotic fluid. The gestation time needs to be over 36 weeks, the 
membranes need to have ruptured and no contraindications against invasive monitoring 
may be present (Luttkus et al. 2004, Devoe 2011).  
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A drawback of this method is that the CTG tracing must be correctly classified 
before STAN® if the recommended action is to be the correct one (Amer-Wåhlin et al. 
2007). Nevertheless, a recent Cochrane Review concludes that monitoring the fetus 
using CTG plus ST waveform analysis results in fewer fetal blood samples (risk ratio 
[RR] = 0.61), fewer operative vaginal deliveries (RR = 0.90) and fewer admissions to 
special care units (RR = 0.89) in comparison to CTG monitoring alone (Neilson 2012). 
According to a meta-analysis on ST analysis of fetal ECG (Becker et al. 2012), the 
additional use of ST analysis reduces also the overall incidence of operative deliveries. 
The incidence of metabolic acidosis was reduced in most randomized studies, but was 
not statistically significantly less than when ST analysis was used (RR = 0.72, 
confidence interval 0.43–1.19). However, by Cochrane way of analysis, the reduction in 
the occurrence of metabolic acidosis was significant. 
To overcome the problems of subjective interpretation of CTG, Costa et al. used a 
computerized system which analyses the features of the CTG tracings as well as the ST 
changes. This method may improve the predictability of neonatal acidemia (cord pH ≤ 
7.05), but the result is handicapped by a small number of acidotic fetuses (Costa et al. 
2009). Thus, computerized monitoring systems which analyze various parameters of the 
CTG and the ECG might help to identify intrapartum fetal acidosis more accurately 
than CTG alone. 
2.4 Power spectral analysis 
2.4.1 Analysis of FHRV by power spectral analysis 
The fetal heart rate oscillates at specific frequencies, and the duration of the R-R 
interval changes continuously around a mean value, s the negative feedback and time-
delay of the cardiovascular control system operate (Akselrod et al. 1981, Malliani et al. 
1994a). Power spectral analysis is used to investigate the frequency content of heart 
rate fluctuations, and to estimate the effect of neural regulation on heart rate patterns 
(Verklan et al. 2004, Kwon et al. 2011). An advantage of spectral analysis for studying 
heart rate variability is that the amount of variabil ty and the oscillation frequency can 
be quantified simultaneously. A series of sequential R-R intervals from ECG data are 
decomposed into a sum of sinusoidal functions of different amplitudes and frequencies 
by a fast Fourier transform algorithm. This makes un een, minute changes in FHRV 
objectively detectable (Verklan et al. 2004).  
When heart rate variability is decomposed in the frequency domain by spectral 
analysis, the relationships among various frequency components and specific control 
processes can be established (Groome et al. 1994). The low-frequency (LF) spectral 
band, which stretches from 0.04 Hz to 0.15 Hz (from 2.4 to 7.8 cycles / min), 
corresponds mainly to sympathetic and parasympathetic control, and the high-
frequency (HF) band, from 0.15 Hz to 1.0 Hz (from 7.8 to 60 cycles / min), corresponds 
to parasympathetic control (Anonymous1996). The mid-frequency (MF) band, which 
resides between the LF and HF bands, may be calculated separately; this spectral band 
is thought to relate to the baroreceptor reflex (Li et al. 2004, Chatow et al. 1995).The 
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very low-frequency (VLF) band (< 0.04 Hz) is not usually used when short-term 
recordings are interpreted, since the physiological basis for the VLF band related to 
FHRV is not well understood, and may, in fact, be questionable. The low-to-high 
frequency ratio (LF/HF) is assumed to reflect the sympatho-vagal balance 
(Anonymous1996, Malliani et al. 1994b).  
Autonomic cardiac control matures with advancing GA, as verified by analyses of 
the spectral powers of FHRV. Ferrazzi et al. found that the HF spectral power 
(corresponding to vagal cardiac control) was not present at 26 weeks of gestation, but 
was evident at 36 weeks of gestation (Ferrazzi et al. 1989). Overall, both the LF and the 
HF spectral powers increase and the LF/HF ratio diminish with advancing GA. This 
indicates greater parasympathetic control as the fetus matures (Van Leeuwen et al. 
2003). Besides GA, the spectral powers of FHRV are also ffected by fetal behavioral 
patterns, at least before labor (Visser et al. 1982). 
2.4.2 Spectral analysis of FHRV in detecting fetal acidosis 
The way in which fetal oxygen deficiency affects the spectral powers of FHRV has 
been studied by different procedures and methods an at various spectral bandwidths. 
Acute oxygen deficiency in ovine fetuses has been induced by occluding the 
maternal abdominal aorta, by decreasing maternal inspired oxygen, and by 
embolization of the placenta. The experimental studies on the effect of fetal hypoxia on 
spectral analysis of FHRV are summarized in Table 4. In acute hypoxemia, all spectral 
powers of FHRV increase. During a 10-minute recovery after induced hypoxemia HF 
spectral powers increase compared to LF powers, sugge ting increased parasympathetic 
activity during recovery (Yu et al. 1998, Min et al. 2002). Acute hypoxia and acidosis 
induced by repeated umbilical artery embolism (three times at an hourly interval; fetal 
pH decrease from 7.33 to 7.08) causes a decrease in FHR. All spectral powers increase 
significantly over baseline values during the study period; the highest increase occurs in 
the VLF and LF bands (Li et al. 2004). This indicates that fetuses in distress react to 
acute hypoxemia by increasing their autonomic drive. 
There are only a few clinical studies published on the association between FHRV as 
assessed with spectral analysis and fetal hypoxia dur ng labor (Kwon et al. 2011, Chung 
et al. 2001, Salamalekis et al. 2006, van Laar et al. 2010). These studies are 
summarized in Table 5. The study periods, definitios f hypoxemia and acidosis, and 
the ranges of spectral bands used vary among the studie . Hypoxemia (cord artery pH < 
7.15 or < 7.20) seems to increase VLF, LF and MF spectral powers, although there are 
also contradictory findings. Chung et al found that the LF power decreases two hours 
before delivery in hypoxemic fetuses (Chung et al. 2001) and that there is no change or 
a decrease in the HF spectral power. The LF/HF ratio ises, but this has been measured 
in only one study (Kwon et al. 2011).  Acidotic fetuses (cord pH < 7.05) have been 
studied only in one study (van Laar et al. 2010). Laar et al found that during the last 30 
minutes of labor, there is no difference in LF or HF powers between acidotic and 
control fetuses. However, the relative LF power (LFper total power) was significantly 
increased, and the relative HF power decreased in the hypoxic group.  
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Although the results vary by study protocol, fetal responses to oxygen deficiency 
and changed circumstances are reflected in the changed balance of spectral powers of 
FHRV, with as a slight shift towards sympathetic predominance. 
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Table 4.  Spectral powers of fetal heart rate variability and hypoxia. Experimental studies on ovine fetuses. 
Author 
Publ. Year 








200 beat-to-beat  
segment prior and after 
60 s of occlusion of the 
maternal aorta 
hypoxemia (oxygen tension 
drop from 2.2 to 1.2 kPa) 
modest change in pH 
- VLF ( ~0.00Hz ) disappeared due 
to hypoxemia 
- LF (~0.065Hz) markedly increased 
- HF ( ~0.50Hz) peak appeared 
after hypoxemia 
Yu et al. 
1998 
7 FFT (pulse interval 
measured from arterial 
pressure wave) 
100 s segments; 2 before, 
7–8  during, and 2 
segments after hypoxia 
(maternal oxygen 
deficiency) 
PO2 12–14.5 mmHg (mild 
hypoxemia) 
PO2 10–11.9 mmHg (moderate 
hypoxemia); no pH changes 
- Spectral power from 0.04 to 
0.45Hz increased due to mild and 
moderate hypoxemia 
Min et al. 
2002 
8 Smoothed power 
spectral analysis 
60 s segment before, 
during and after 60 s of 
occlusion of the maternal 
aorta 
Pa O2 decreased (hypoxemia);  
no change in pH 
- LF (0.04–0.15 Hz),   HF (0.4–
1.5Hz)  and  LF/HF increased due to 
hypoxemia 
 
Li et al. 
2004 
7 Autoregression 
(pulse interval measured 
from arterial pressure 
wave) 
 
2 min before and after 3 
placental embolisms at 
hourly intervals (0h, 1h, 
2h) 
PO2 fell by 50%   




- VLF (0.01–0.025 c/b) and  LF 
(0.025–0.125 c/b) increased 
markedly due to hypoxia 
- MF (0.125–0.20 c/b)  and  HF 
(0.20–0.50 c/b) increased  
- rel VLF and rel LF decreased 
- rel HF increased  
Publ. Year=publication year; s= seconds; min=minute(s); h=hour(s); FFT= fast Fourier transform; c/b=cycle/beat (can be converted to Hz by 
dividing with the average R-R interval); rel= relative power i.e. power divided with total power 
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FFT 2 hours before 
delivery 
Hypoxia: pH <7.15 + BE< -
8mM/l (n=14) 
Distress: Abnormal CTG + 
apH>7.15 (n=26) 
- VLF (<0.04 Hz) increased due to hypoxia 
- LF (0.04-0.15 Hz) and  HF (0.15-0.4 Hz) 
decreased due to hypoxia 






Matching pursuit Second stage of labor Hypoxemia: non-
reassuring CTG and pH < 
7.20 
- VLF (<0.04 Hz)  and   LLF (0.04-0.08 Hz) 
increased due to hypoxia 
- LF (0.08 -0.15 Hz) and  HF (>0.15 Hz): no  
significant change  





FFT Last 30 min of labor 
and 3 to 2 hours 
before birth;  values in 
5min intervals 
Acidosis: apH<7.05 - LF (0.04-0.15 Hz) and  HF (0.4-1.5 Hz): no 
difference between acidotic and control 
groups 
- rel LF increased due to hypoxia 










Last 2 hours of 
delivery, segment of 
256 beats 
Hypoxemia: apH <7.20 
 
- Total  (0.04-1.0 Hz), LF (0.04-0.15Hz) and 
MF (0.15-0.5Hz) increased due to 
hypoxemia 
- HF (0.5-1.0 Hz) and  LF/ (MF+HF):  no 
significant change  
- LF/HF increased due to hypoxia 
- rel LF and rel HF: no significant change 
Publ. year=publication year; GA= gestational age at weeks; FFT= fast Fourier transform; US=ultrasound; apH= umbilical artery pH; BD=base deficit; 
VLF=very low frequency; LF=low frequency; MF=mid frequency; HF=high frequency;  rel= relative power i.e. power divided with total power 
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3. AIMS OF THE STUDY 
The aim was to investigate the effect of intrapartum acidosis on spectral powers of 
FHRV in term human fetuses. We hypothesized that, since power spectral analysis of 
FHRV measures changes in the autonomic nervous control of FHRV, power spectral 
analysis might detect fetal acidosis earlier and more accurately than CTG and STAN®, 
and that power spectral analysis could thus be usedto monitor fetal wellbeing during 
labor and delivery. 
 
The specific aims were to study: 
1. whether intrapartum spectral powers of FHRV could be used for identifying fetuses 
at risk for birth acidosis. 
2. whether changes in spectral powers of FHRV at the tim of significant ST events in 
the fetal ECG  are associated with fetal metabolic ac dosis. 
3. whether spectral powers of FHRV are associated withintrapartum FBS pH-values 
measured at the same time as the power spectral analysis is made. 
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4. SUBJECTS AND METHODS 
4.1 Study design and subjects of studies I-IV 
STUDY I 
 
This preliminary study included 14 singleton fetuses with a GA exceeding 35 weeks 
delivered at the Turku University Hospital. Fetal R-R interval data was recorded with 
STAN® (Neoventa Medical, Mölndal, Sweden) for 15 minutes at a median of two hours 
before delivery. One two-minute, stable, noise-free signal segment was selected for 
power spectral analysis. Umbilical cord blood samples were obtained immediately after 
birth. The fetuses were divided into two groups: those with a cord artery BD value < 8 
mmol/l (n = 8) and those with a cord artery BD value 8-12 mmol/l (n = 6) at birth.  
The spectral powers of FHRV were compared between the groups, and the 
correlation between spectral powers and BD values was calculated. 
 
  
Study groups Studied FHR period Main outcome measure 
1) Cord BD < 8 mmol/l 
(n=8) 
2) Cord BD 8-12 mmol/l 
(n=6) 
2 min segment at a median 
of 2 hours before delivery 
Intergroup  FHRV 
difference  
Correlation between 
spectral powers of FHRV 
and cord BD values 
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STUDY II  
 
The study comprised 334 fetuses with a GA exceeding 35 weeks. Data was collected 
from 12 Nordic delivery units as a part of a Nordic observational multicenter study 
(Amer-Wåhlin et al. 2002). Fetal ECGs were recorded during the active phase of labor, 
and the umbilical cord acid-base status was measured aft r birth. The fetuses were 
divided into two groups according to their cord arterial acid-base status: 1) acidotic 
fetuses with a pH < 7.05 (n = 15) and 2) non-acidotic fetuses with a pH ≥ 7.05 (n = 
319).  
The spectral powers of FHRV from the last hour of delivery were assessed in 2-
minute signal segments and the change in spectral powers between the study groups 
was measured. The association between spectral powers from the study period and cord 




Study groups Studied FHR period Main outcome measure 
1) Cord pH <  7.05 (n=15) 
2) Cord pH ≥ 7.05 (n=319) 
Last hour of intrapartum 
fetal ECG recording 
Changes in spectral powers 
of FHRV in the course of 
delivery between the study 
groups 
Association between 
spectral powers and cord 
pH 





This was a case-control study with 34 fetuses, all with a significant ST event in the fetal 
ECG. Data was collected from ten European labor wards as a part of a European 
multicenter project on intrapartum fetal monitoring (Luttkus et al. 2004). Twenty-two 
fetuses were acidotic (cord arterial pH ≤ 7.05) and 12 fetuses were not (cord pH ≥ 
7.20). The median LF/HF ratio of FHRV was measured within a period of one hour 
before and one hour after the significant ST event. Spectral powers were measured in 2-
minute signal segments.  
The relative change in the LF/HF ratio [(median LF/H after - median LF/HFbefore)/ 
median LF/HFbefore] at the time of the ST event was calculated. The magnitude of 
change in spectral powers was analyzed in order to es ablish a cut-off value to 
distinguish fetuses with metabolic acidosis at birth (pH ≤ 7.05 and BD ≥ 12 mmol/l) 




Study groups Studied FHR period Main outcome measure 
All fetuses had a significant 
ST event in fetal ECG  
1) Cord apH  ≤  7.05 
(n=22) 
2) Cord apH > 7.05 (n=12) 
One hour before and one 
hour after a ST event 
Change in LF/HF ratio in 
relation to a significant ST 
event 
Prediction of birth acidosis  





This was a retrospective study with 462 fetuses whohad a normal pH-value (pH > 7.20; 
controls) in a scalp blood sample and 81 fetuses who had a low pH-value (pH ≤ 7.20; 
low-FBSpH-fetuses). The fetuses for this study were sel cted from the same data base 
as those for Study III (Luttkus et al. 2004). The low-FBSpH-fetuses were further 
divided into two subgroups according to the degree of acidemia: fetuses with FBS pH 
7.11–7.20 (n = 58) and fetuses with FBS pH ≤ 7.10 (n = 23).  
Two additional groups with two measure points during delivery were chosen: in the 
first group (108 fetuses), both the first and the last FBS pH were normal, and in the 
second group (40 fetuses) the initial FBS pH was or the 30 min CTG segment at the 
beginning of the recording was normal but the last-FBS pH-value was low (pH ≤ 7.20).  
FHRV was measured in 2-minute segments from a 14-minute period prior to FBS. 
The intergroup difference in spectral powers of FHRV between the controls and low-
FBSpH-fetuses and between the subgroups were measured. The correlation between 
spectral powers and the concomitant FBS pH-value was calculated to examine how 
FHRV associates with fetal intrapartum pH-values. Further, the change in spectral 
powers of FHRV during labor was assessed in fetuses with repeatedly normal FBS pH-




Study groups FHR period studied Main outcome measure 
1) FBS pH > 7.20; (n=462) 
2) FBS pH ≤ 7.20; (n=81) 
• FBS pH 7.11–7.20   
(n=58) 
• FBS pH ≤ 7.10 (n=23) 
14 min preceding last FBS 
 
14 min preceding first FBS 
or 30 min during normal 
CTG 
Association between 
spectral powers of FHRV 
and concomitant FBS pH-
value 
Intergroup difference in 
FHRV 
Change in spectral powers 
in the course of delivery 
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4.2 Data acquisition and signal processing 
The fetal ECGs was recorded during delivery with an intrauterine scalp electrode 
attached to presenting part of the fetus using a STAN monitor (Cinventa Ab, Mölndal, 
Sweden; Study I) and a STANS 21 monitor (STAN®, Neoventa Medical, Mölndal, 
Sweden; Studies II-IV) (Figure 2). The fetal unipolar ECG lead configuration consisted 
of a single-helix scalp electrode and a maternal skin electrode. STAN® provides the 
averaged QRS complex and an instantaneous plot of each R-R interval at a resolution of 
2 ms (Rosén et al. 1989). R-peaks were detected, and R-R intervals were measur d and 
digitized at a sampling rate of 500 Hz (1000 Hz in Study I). The R-R interval data sets 
were stored digitally as part of STAN® data archiving, and the intervals from the study 
period were analyzed off-line. The R-R interval data sets were transformed to a 
continuous digital signal by linear interpolation, and then the event series was 
resampled at the rate of 16 Hz. The reciprocal of each R-R interval was computed to 
obtain the respective instantaneous heart-rate reading. The data was analyzed in 2-
minute segments. In the case of large signal breaks in this R-R data segment, a new 
segment was started immediately after a break to minimize loss of data. 
 
Figure 2.  Left: Cardiotocogram. Right: Intrauterine scalp e ectrode to register the 
electrocardiogram and R-R interval, and an intrauterine pressure analyzer to 
measure contractions. (©Neoventa Medical AB, with permission) 
4.3 Power spectral analysis 
The FHRV was measured with power spectral analysis in 2-minute signal segments. 
The quality of these segments was checked by a signal analyst, and data analysis was 
performed with no knowledge of the clinical data. Fast-Fourier-transformed power 
spectra were computed for the FHR signal segments (MATLAB®-oriented tailor-made 
signal analysis - program, MARAPS, Tampere, Finland) (Välimäki et al. 1999).  
In the preliminary study (Study I), a slightly wider frequency band was used than in 
the subsequent studies. The frequency at outset was 0.03 Hz. Three spectral bands were 
Subjects and methods 
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calculated: low-frequency (LF; from 0.03 Hz to 0.07 Hz), mid-frequency (MF; from 
0.07 Hz to 0.13 Hz), and high-frequency (HF; from 0.13 Hz to 1.0 Hz). In Studies II-
IV, the FHRV spectrum was integrated over the total frequencies from 0.04 to 1.0 Hz. 
The LF band was integrated over frequencies from 0.04 Hz to 0.15 Hz, and thus 
included most of the mid-frequency band used in Study I. The HF band was from 0.15 
Hz to 1.0 Hz. The LF/HF ratio was calculated. All data on spectral variability are 
presented in arbitrary units (AU).  
To minimize the effect of FHR on FHRV, the coefficient of component variance 
(square root of power spectra / mean R-R interval) w s calculated (Hayano et al. 1990).  
4.4 Statistical analysis 
Study I: The intergroup difference was tested with a Mann-Whitney U-test. The 
correlation between the spectral powers and BD values was calculated by the Spearman 
correlation test, where r = 1.0 represents perfect correlation.  
Study II: Longitudinal data of FHR and FHRV parameters from the last hour of 
recording were analyzed with analysis of variance (ANOVA) for repeated measures, 
where the grouping factor (acidotic or control) and the within factor (time of study 
period) were independent variables. Because the distribution of the data was skewed, 
the FHRV values were log-transformed for repeated measures analysis (excluding 
FHR). If there were significant interactions between the group and time of study period, 
Student’s t test was used for further analysis. The association between FHR or FHRV 
(dependent variables) and gestational age, birth weight, and cord arterial pH-value 
(continuous independent variables) was analyzed with the linear model for repeated 
measures. The time of the study period was used as the repeated factor in the linear 
models. 
Study III: For each fetus, a relative change in theLF/HF ratio was calculated 
[(median LF/HFafter - median LF/HFbefore)/ median LF/HFbefore] in association with an ST 
event. The best cut-off value to identify fetuses with metabolic acidosis at birth was 
determined by a receiver operating characteristic (ROC) curve. Logistic regression 
analysis was used to test whether the same cut-off value could be used for both an 
increase and a decrease in the LF/HF ratio. 
Study IV: The associations between spectral powers and FBS pH-values were 
analyzed with the Spearman Partial Correlation coeffici nt test. As GA is known to 
affect FHRV (Assali et al. 1977) and spectral powers (van Laar et al. 2009), GA was 
used as a covariate when calculating the correlation between spectral powers and the 
FBS pH- value. The differences of the spectral powers between the subgroups were 
tested with the t-test. 
The clinical data were analyzed with Student’s t-test, Wilcoxon’s two-sample test or 
Fisher’s exact test, as appropriate. The results are expressed as mean (range) or median 
[range], as appropriate (Studies II, III and IV).  
 A P–value < 0.05 was considered significant. Statistical analyses were performed 







5.1 Spectral powers of FHRV during labor, and in relation to 
umbilical cord acid-base status (Studies I and II) 
In Study I, the MF spectral powers correlated inversely with cord artery BD (r = -0.6; p 
= 0.02). The total and MF FHRV of fetuses with mild metabolic acidosis (cord BD 8-12 
mmol/l) at birth was reduced (p = 0.01 in both comparisons) at a median of 2-hours (1–
8 h) before delivery (Figure 3). The changes in FHRV were no accompanied by 
changes in the mean heart rate.  
In Study II, fetuses that were acidotic at birth (cord pH ≤ 7.05) had a higher LF/HF 
ratio of spectral powers than non-acidotic fetuses (p = 0.002) during the last hour of 
intrapartum monitoring.  The LF, HF and total spectral powers of FHRV gradually 
increased in the acidotic fetuses, but then dropped near delivery (Figure 4). Total and 
LF spectral powers and the LF/HF ratio were inversely associated with cord pH-values 
(p < 0.001; p < 0,001; p = 0.007; respectively). In summary, hypoxia increases initially 
spectral powers of FHRV, and the FHRV decreases as acidosis becomes more 
pronounced. 
 
Figure 3. Left: FHRV spectral powers of eight fetuses with cord arterial BD values 8-12 
mmol/l. Right: Spectral powers of six fetuses with BD < 8 mmol/l. The fetuses 
with BD 8-12 mmol/l had significantly lower total (0.03-1.0 Hz) and mid-
frequency (0.07-0.13 Hz) spectral powers of FHRV (p = 0.01). (AU = arbitrary 






Figure 4. FHRV during the last hour of labor in acidotic (pH < 7.05) and non-acidotic 
(control) fetuses (pH > 7.05). There was a significant interaction between the 
study groups and time of the study period in total (P = 0.018), LF (P = 0.03) 
and HF FHRV (P = 0.009; ANOVA for repeated measures). The LF/HF ratio 
was greater in the acidotic group (P = 0.002) and there was no significant 
interaction. The spectral powers of FHRV are presented in arbitrary units 
(AU). * = significant difference between groups (P < 0.05; two sample t test). 
(Study II) 
5.2 Intrapartum spectral powers of FHRV in relation to fetal 
scalp pH (Study IV) 
Fetuses with FBS pH ≤ 7.20 (intrapartum hypoxia) had increased spectral powers of 
FHRV compared with controls (FBS pH > 7.20) (p = 0.038). Interestingly, the fetuses 
with the lowest FBS pH (≤ 7.10) had significantly lower spectral powers when 
compared to fetuses with FBS in the pH-range 7.11-720 (p = 0.047) (Figure 6). On the 
whole, the individual variance of spectral powers was wide (Figure 5). In the process of 
labor and delivery, fetuses developing intrapartum hypoxia (normal first scalp pH-value 




spectral powers of FHRV from the first to second measure points when compared with 
fetuses with repeatedly normal scalp pH-values (> 7.20) (p = 0.0005). 
 
Figure 5. Total, LF, and HF spectral powers of FHRV in control fetuses (scalp pH > 
7.20), and in fetuses with a low pH in FBS (pH ≤ 7.20), and in subgroups with 
FBS pH 7.11-7.20 and FBS pH ≤ 7.10.  p-values are presented between the 
controls and low-FBS-fetuses, and between the subgro ps. Mean spectral 
values are in arbitrary units (AU). (Study IV) 
5.3 Correlation between FHRV and intrapartum FBS pH-
values (Study IV) 
Total spectral powers of FHRV of low-FBSpH-fetuses (pH ≤ 7.20) correlated positively 
with the concomitant FBS pH (r = 0.29; p = 0.008), but the correlation was poor and 
negative in control fetuses (r = - 0.15; p = 0.001) (Figure 6). In a subgroup of fetuses 
with the lowest FBS pH (≤ 7.10), HF spectral powers of FHR variability correlat d with 
FBS pH (r = 0.50; p = 0.018).  
In summary, the HF spectral power of FHRV decreased with decreasing 
concomitant scalp pH-values. This indicates that there is decreased vagal activity in 
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Figure 6. Correlation between total spectral power of FHRV and the FBS pH-values. 
The spectral power of FHRV is presented in arbitrary units (AU). (Study IV) 
5.4 FHRV in relation to ST events (Study III) 
A relative change greater than 30 % (increase or decrease) in the LF/HF ratio of FHRV 
in association with a ST event was associated with fetal metabolic acidosis (cord artery 
pH ≤ 7.05 and BD ≥ 12 mmol/l) (Figure 7). A change of this magnitude pr dicted fetal 
metabolic acidosis with a sensitivity of 89 % (95 % Cl 68–100 %) and specificity of 80 
% (95 % Cl 64–96 %).  Out one out of nine fetuses with metabolic acidosis was not 
identified with this cut-off value. Five fetuses who did not have metabolic acidosis had 
a change of more than 30 % in the LF/HF ratio, but three did have signs of oxygen 
deficiency - the cord artery pH was ≤ 7.05 and the BD > 8 mmol/l (Figure 8).  
In summary, if the LF/HF changed markedly during delivery, 85 % of the fetuses 




























































Figure 7. ROC curve of the relative change in the LF/HF -ratio of FHRV in relation to a 
significant ST event for predicting metabolic acidemia in arterial umbilical 
cord blood samples. (Study III) 
 
Figure 8. Relative change in spectral powers of the LF/HF ratio of FHRV associated 
with a significant ST event vs. cord arterial BD values in 34 fetuses. Cases 
marked with an arrow represent a fetus with pH ≤ 7.05, but BD 8- 12 mmol/l 






Accurate detection of intrapartum fetal acidosis is crucial for the prevention of neonatal 
morbidity, especially cerebral damage. Unnecessary operative interventions should be 
avoided to prevent maternal morbidity and complications in future pregnancies. Making 
clinical decisions adequately is challenging when based on interpretation of the CTG 
alone, but this is a drawback of STAN® method, as well. The driving concept of the 
studies in this thesis was to examine if spectral analysis of FHRV could provide 
objective information on fetal responses to oxygen d ficiency by measuring hypoxia-
related autonomic nervous system activation. Based on the results in our preliminary 
study (Study I), we proceeded to examine the value of spectral analysis in larger series 
of human fetuses, aiming to test whether intrapartum hypoxia can be detected with 
power spectral analysis of FHRV. 
6.1 FHRV and intrapartum hypoxia 
There appeared to be a large intraindividual variation in spectral powers of FHRV, and 
thus a single measure is not sufficient for determining fetal wellbeing. If the FHRV 
varies largely, this identifies a fetus capable of responding actively to the stress of labor 
and delivery, even if acidemia ensues. We found that during delivery, a marked (> 30 
%) change in the LF/HF ratio of FHRV at the time of a significant ST event was 
associated with fetal metabolic acidosis (pH ≤ 7.05 and BD > 12.0 mmol/l), or a low 
cord arterial pH-value (≤ 7.05) at birth. These results are in line with experimental 
studies showing that progressive metabolic acidosis f llowing repeated umbilical cord 
occlusions leads to an increase in FHRV, although FHRV may also decrease with 
progressing acidemia (Westgate et al. 1999a). Clearly, changes in the FHRV are an 
important variable to be followed.  
When studying the association of spectral powers with concomitant intrapartum 
hypoxia estimated by scalp FBS pH, we found that a he lthy fetus responds to hypoxia 
by increasing its FHRV. In contrast, when the compensatory reserves of a fetus have 
been consumed, FHRV decreases due to deeper acidosis. Increased vagal activity may 
be critical for fetal outcome (Frasch et al. 2009, Groome et al. 1999), and a lack of 
vagal activation compromises chemoreceptor-mediated fetal circulatory centralization 
during hypoxia (Jensen et al. 1999). LF and especially HF spectral powers of FHRV 
correlate with vagal activity (Groome et al. 1999). Our finding, that fetuses with the 
lowest intrapartum pH (FBS ≤ 7.10) had smaller HF FHRV compared with fetuses with 
higher FBS pH (7.11- 7.20) is in line with this hypothesis, as fetuses with the lowest 
FBS may already have consumed their compensating reserv s. Thus, if the HF spectral 





6.2 FHRV and acidosis at birth  
In fetuses acidotic at birth, all spectral powers of FHRV increased initially, but then 
gradually dropped as labor progressed. This finding agrees with previous human and 
experimental studies. In human fetuses, hypoxia increases the FHRV (Kwon et al. 2011, 
Salamalekis et al. 2006), whereas in experimental studies marked acidosis decreases the 
FHRV (Ikeda et al. 1998, Dalton et al. 1977). The decrease in spectral powers of 
FHRV in acidotic fetuses may represent a sign of fetal decompensation due to 
progressive hypoxic stress. 
6.3 FHRV and non-hypoxic ST changes 
It is known that ST changes in the fetal ECG may be du  to other conditions than 
hypoxia, e.g. prematurity, infection, maternal fever, f tal myocardial dystrophy, cardiac 
malformations, and fetal stress hormone surges due to contractions during labor (Amer-
Wåhlin et al. 2011). During a normal, reactive CTG, these changes are thought to 
appear as a consequence of arousal reactions indicat g that a fetus is responding to the 
strain of labor with surges of stress hormones (Amer-Wåhlin et al. 2011). Nevertheless, 
clinicians can be confused in front of the STAN® alarms generated by such conditions, 
and it would be most useful if harmless ST changes could be distinguished from the 
ones caused by hypoxia. Based on our results, spectral analysis of FHRV may help to 
differentiate non-hypoxic ST changes from hypoxic ST changes, since a marked change 
in the relative spectral powers was associated withfetal metabolic acidosis (Study III, 
Fig. 8.). This finding needs to be corroborated in a larger study sample of fetuses with 
arousal reactions and, in larger group of fetuses with a poor outcome.  
6.4 Methodological considerations 
When fetal wellbeing during delivery is monitored with the STAN® method, the R-R 
interval data are freely available for analysis andspectral calculations. Thus, with slight 
equipment modifications, intrapartum FHRV data could be easily and continuously 
obtained simultaneously with fetal ECG, and any possible changes in FHRV spectral 
powers could be promptly analyzed.  For future research, agreement on spectral bands 
is necessary in order to get comparable results. 
Spectral analysis of FHRV requires a stationary signal, and for calculation of LF 
variability, a continuous signal segment of at least 75 seconds is needed (Berntson et al. 
1997). This is a shortcoming inherent to spectral analysis of FHRV, because during 
delivery, the FHR data is often non-stationary - there are signal breaks and large 
fluctuations caused by uterine and fetal activity. Therefore, we have studied the FHRV 
in short, two-minute signal segments. If there were large signal breaks in the two-
minute R-R data segments, a new segment was started immediately after a break to 
minimize loss of data. Despite these procedures, signal segments were lost in 43-67% 




Because the FHR and FHRV are also dependent on each other, all FHRV data were 
corrected for baseline heart rate in studies I-IV (Hayano et al. 1990). Several additional 
factors, such as GA, fetal activity and sleep state, uterine contractions, and medication 
also affect FHRV (Park et al. 2001, Divon et al. 1985, Zimmer et al. 1998, Reynolds 
2010). Modulation of FHRV matures with advancing GA, and i  near-term fetuses GA 
affects the spectral powers of FHRV (van Laar et al. 2009). This was also found in 
Study II, where HF spectral power (corresponding to vagal activity) increased with 
advancing GA. However, there were no differences in GA between the study groups in 
any of the studies. The number of gestational weeks was used as a covariate in Study 
IV, when calculating the correlation between spectral powers and the FBS pH-value, 
but this did not affect the result.  
During labor, fetal movements decrease and, when thy do occur, they are generally 
associated with uterine contractions (Natale et al. 1981, Wittmann et al. 1979). During 
acidosis, fetal movements decrease further (Natale et al. 1981). Fetal movements may 
increase LF FHRV, but there have also been contradictory results (Breborowicz et al. 
1988, Zimmer et al. 1988). Fetal movements were not assessed in this study. However, 
to minimize the effect of occasional fetal movements on spectral powers, several signal 
segments from each study period were analyzed and me ian spectral values were 
calculated. As hypoxia increases LF FHRV, any increase in spectral powers due to fetal 
movements in the control group would have narrowed th  difference between the study 
groups by increasing LF FHRV.  
Contractions are unlikely to contribute to the present results, since they do not occur 
at a frequency that could interfere with the detection by spectral analysis, i.e. at least 
three times within a 2-minute signal segment. 
Maternal analgesia during delivery may also affect FHRV (Palmer et al. 1999, 
Capogna 2001). However, the incidence of these FHR changes is low (6-12%), and all 
changes have been transient and resolved within 30 minutes (Palmer et al. 1999). 
Therefore, we decided not to analyze separately fetuses by maternal analgesia. 
6.5 Strengths and limitations 
We studied intrapartum hypoxia in a large series of human fetuses collected as a part of 
multicenter studies. Despite having strict criteria for fetal and neonatal acidosis in 
Studies II-IV (FBS pH ≤7.20, and even ≤7.10; cord arterial pH ≤ 7.05 and BD ≥12 
mmol/l) we had many affected fetuses with intrapartum acidosis and/or metabolic 
acidosis at birth.   
We analyzed FHRV in human fetuses from new viewpoints, and studied how a fetus 
adapts to normal labor and delivery, and what happens if the fetus has acidosis.  
The number of studied fetuses was not very large in the preliminary study (Study I) 
and in Study III. Especially the number of fetuses with “false ST alarms” was small, 
and the result of Study III needs to be confirmed in future studies. Further, the time lag 
from recording of the FHRV segments to measurement of the acid-base values at birth 
was occasionally (in studies I and III) several hours, which is far too long. Situations 




may be analyzed before a fetus is exposed to hypoxic condition. However, in study III, 
the median time lag to birth was 48 minutes, which is a reasonable time -interval. 
The main weaknesses of the spectral studies are that neither have the spectral bands 
of FHRV been standardized nor have the methods beenestablished. Thus, the results 
cannot straightforward be compared with other studies. 
6.6 Clinical implications 
Can spectral analysis of FHRV be used in clinical pr ctice?  Our studies show that 
interpretation of complex FHR patterns can be aided by quantifying FHRV. We have 
seen that changes in spectral powers of FHRV are moarked in hypoxic and acidotic 
fetuses than controls, and that these changes in spectral powers occur even before 
changes in the basal heart rate are detectable (Study I). Further, a relative change in the 
LF/HF ratio in association with a significant ST event in the fetal ECG predicts 
metabolic acidosis in majority of the cases; the LF/HF ratio could be useful for 
separating ST events related to hypoxia from ST events due to physiological arousal 
reactions. This additional information on fetal well-being may help to prevent 
unnecessary operational deliveries. The range of normal spectral powers of FHRV is, 
however, wide and depends on the individual maturation l state and physiological 
reserves of the fetus. Thus, spectral powers of FHRV should be analyzed longitudinally, 
and momentary spectral powers should be completed with those obtained earlier during 
labor (trend analysis).  
6.7 Future research 
Power spectral analysis is an interesting method for analyzing FHRV objectively during 
labor and delivery. Since the data in the present study is rather limited, larger 
observational studies are necessary. These studies wer  made off-line, and now on-line 
studies are needed to determine the clinical usefuln ss of spectral analysis in detecting 
fetal intrapartum hypoxia and acidosis. The challenge of on-line studies will be signal 
loss, but when short signal segments during labor are studied continuously, information 
loss is minimized.  
Some interesting research question arise: Can spectral analysis of FHRV be used to 
differentiate non-significant ST events from hypoxic ST events in STAN® recordings? 
Is there an association between spectral powers and the amount of ST changes? The 
answers to these questions are important and raise a n ed for randomized clinical 
studies. 
The relation between spectral powers of FHRV and various CTG features, e.g. FHR 
decelerations, also need attention. The influence of maternal diseases, e.g. diabetes and 
hypertension, on fetal autonomic nervous control of FHRV is not known and power 
spectral analysis presents itself as a method that could be used to examine these 
important relations.  
Summary and conclusions 
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7. SUMMARY AND CONCLUSIONS 
Intrapartum FHRV was studied in human fetuses with power spectral analysis. R-R 
interval data was recorded with a STAN® monitor and fetal data was collected as part of 
multicenter STAN® studies. Spectral powers of FHRV were compared between acidotic 
and control fetuses, and the associations between sp ctral powers, acid-base values of 
umbilical cord arterial blood and ST changes of the fetal ECG were studied. 
 
1. During the course of labor, spectral powers of FHRV were increased in all 
fetuses, suggesting that changes in spectral powers reflect the effects of autonomic 
cardiac control in mature fetuses in response to the s ress of labor. This increase was 
more pronounced in fetuses with intrapartum hypoxia. In fetuses that were acidotic at 
birth, all spectral powers of FHRV dropped near delivery. 
 
2.  The association between a spectrum of FHRV and concomitant pH-values in 
blood samples taken from the scalp of the fetus was poor, and the range of spectral 
powers was wide. Thus, a single measure cannot identify a fetus at risk of acidosis. The 
technique might be useful for longitudinal assessment of changes in spectral powers of 
FHRV with time during labor: longitudinal data could provide more information on the 
oxygen state of the fetus. 
 
3. Low-to-high frequency spectral powers of FHRV changed markedly in relation to 
fetal ECG ST events in fetuses with metabolic acidosis at birth. This change in the 
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Abstract
Fetal distress changes the function of the autonomic nervous system. These changes are
reflected in the fetal heart rate and can be quantified with power spectrum analysis of heart rate
variability. The purpose of this study was to find out whether spectral components of fetal heart
rate variability (FHRV) during labor are associated with fetal cord arterial base deficit values at
birth. The association between FHRV and umbilical cord arterial base deficit was studied in 14
singleton fetuses with normal pregnancy at 35–40 weeks of gestation. Fetal ECG was recorded
 ¨by scalp-electrode using a STAN Fetal ECG monitor (Cinventa Ab, Molndal, Sweden).
FHRV was quantified by computing Fast-Fourier-transformed heart rate (HR) spectra at three
frequency bands: low-frequency (LF) 0.03–0.07 Hz, mid-frequency (MF) 0.07–0.13 Hz and
high-frequency (HF) 0.13–1.0 Hz. We found that total FHRV and MF FHRV were lower in
fetuses with cord arterial base deficit 8 to 12 mmol /L in comparison to the fetuses with normal
cord arterial base deficit value (P 5 0.02 and P 5 0.01, respectively). A linear correlation was
found between the spectral densities and the cord arterial base deficit values (r 5 0.4 and
r 5 0.6, respectively). We conclude that the results suggest changes in the autonomic nervous
cardiac control in fetuses with cord arterial base deficit between 8 to 12 mmol /L. The clinical
applicability of our observations on FHRV in predicting fetal distress remains to be further
studied.  2001 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
The early accurate detection of fetal hypoxia during labor is of crucial importance.
The sensitivity of non-invasive methods such as cardiotocography (CTG) used in
assessing fetal well-being is often limited and the predictive value of an abnormal
FHR pattern is low. Therefore, new tools are required to improve early diagnosis of
fetal hypoxia. The degree of metabolic acidosis as measured from the umbilical
arterial blood after birth reflects the cumulative hypoxic events that have occurred
during the labor [1]. No general consensus has yet been reached on the definition of
the threshold markers of decompensation. However, an umbilical artery base deficit
of 12 mmol /L has been associated with moderate and severe neonatal asphyxic
complications and a base deficit from 8 to 12 mmol /L are connected with minor
complications in the newborn. The normal arterial base deficit values range from 4 to
8 mmol /L [2]. In experimental studies, the autonomic nervous system activation has
been related to early induction of hypoxia [3], whereas depression has been
associated to prolonged situation [4]. The balance of this autonomic nervous cardiac
control can be quantitatively estimated by spectral analysis of heart rate variability
[4]. We wanted to study whether spectral components of fetal heart rate variability
(FHRV) during labor are associated with the values of cord arterial base deficit in
human fetuses at birth.
2. Patients
Fourteen fetuses at 35–40 weeks of gestation after normal singleton pregnancy
were examined. The babies were born on a median of 2 h (1–8 h) after a fetal ECG
had been recorded and the arterial cord blood samples were obtained at delivery. The
mothers did not receive any medication except intravenous oxytocin during the labor.
Epidural analgesia was given to eleven mothers about 2 h before fetal ECG was
recorded.
3. Methods
The fetal ECG was recorded for 15 min with an intrauterine scalp-electrode using a
 ¨STAN Fetal ECG monitor (Cinventa Ab, Molndal, Sweden) and stored on a
magnetic tape with an FM tape recorder (Store 4 DS, Racall Recorders, Southampton,
UK). The fetal ECG was replayed and fed into a PC (Pentium 120 MHz) computer.
The Dasylab (Data Acquisition System Laboratory) program (Dosesoft, Tampere,
Finland) was used for digitizing the fetal ECG signal. One 2 min noise-free signal
segment was visually selected from each ECG. Visual selection was made by a ADP
designer who was blinded to the grouping, clinical details and CTG of the fetuses. A
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Fig. 1. Instantaneous heart rate patterns of a fetus with cord arterial base deficit above 8 mmol /L
(left-hand panel) and another fetus with cord arterial base deficit value below 8 (right-hand panel).
voltage threshold trigger was used to detect each R wave and form an event-series of
beat-to-beat intervals. The R–R intervals were measured at a sampling rate of 1 kHz,
providing a time resolution of 1 ms. The reciprocal of each R–R interval sample was
computed to obtain the respective instantaneous HR signal. After linear interpolation
of consecutive heart beats, the events series was resampled at a rate of 16 Hz. To
avoid aliasing, the signal was low-pass filtered and decimated by 8. The linear trend
was removed from the HR signal. Fast-Fourier-transformed power spectra were then
computed for the HR signal segments (MATLAB oriented tailor-made signal
analysis program, MARAPS, Tampere, Finland) (Fig. 1).
Spectral density of fetal HR variability was integrated over the frequency band of
0.03–1.0 Hz (1.8–60 cycles /min) and over three other frequency bands: low-
frequency (LF) band from 0.03 to 0.07 Hz (1.8–4.2 cycles /min) as an indicator of
mainly sympathetic activity [5], mid-frequency (MF) band from 0.07 to 0.13 Hz
(1.8–7.8 cycles /min) indicating both sympathetic and parasympathetic nervous
control [6] and high-frequency (HF) band from 0.13 Hz to 1.0 Hz (7.8–60 cycles /
min) which mainly corresponds to parasympathetic nervous control [7]. All measure-
ments of spectral densities are given in arbitrary units (AU).
Table 1
Clinical data of the study groups
Fetuses with Base deficit below 2 8 mmol /L Base deficit above 2 8 mmol /L
(n 5 8) (n 5 6)
Pregnancy data
Birth weight (g) 31076465 34326394
Gestational age (wk) 3863 3962
Placental index 0.1760.02 0.1660.03
1-min Apgar score 861 961
Cord arterial blood gas values
Cord arterial pH 7.2360.09 7.3160.08
Cord arterial pCO 6.0362.03 6.661.62
Cord arterial pO 3.861.6 3.361.02
Cord arteiral HCO3** 16.460.7 21.362.1
** P , 0.005.
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Fig. 2. The averaged FHRV spectral densities (6S.D.) of six fetuses with cord arterial base deficit values
from 8 to 12 mmol /L (left-hand panel) and eight fetuses with normal cord arterial base deficit values
(right-hand panel). The fetuses with higher cord arterial base deficit values had significant decrease in total
(0.03–1. 0 Hz) and mid-frequency (0.07–0.13 Hz) fetal heart rate variability. (AU 5 arbitrary units).
4. Statistical analysis
The fetuses were divided into two groups according to the cord arterial base deficit
value: (1) those with umbilical artery base deficit below 8 mmol /L and (2) those with
the base deficit from 8 to 12 mmol /L. The Mann–Whitney U-test was used to
compare the two groups. The correlation between the spectral band HRV densities
and cord arterial base deficit values was estimated by Spearman correlation test.
5. Results
The fetuses with cord arterial base deficit from 8 to 12 mmol /L (n 5 6) had
decreased mean total spectral HRV (8.265.2 S.D. AU, vs. 27.1617.7 S.D., P 5 0.01)
and MF spectral HRV (1.361.0 S.D. vs. 4.662.6 S.D., P 5 0.01, Fig. 2) in
comparison with the fetuses with normal base deficit values (n 5 8). The decrease in
HF or LF oscillations of FHRV did not quite reach statistical significance (1.561.0
S.D. vs. 4.163.5 S.D., P 5 0.05 and 3.462.9 S.D. vs. 5.864.0, P 5 0.05). A linear
correlation between MF spectral HRV and cord arterial base deficit was found
(r 5 2 0.6, P 5 0.02, respectively, tested with Spearman correlation test). There were
no significant intergroup differences in the mean HR, birth weight, gestational age,
fetal gender, placental index (the ratio of the placental weight to birth weight) or
Apgar scores of the babies (Table 1). No abnormalities were found in the
cardiotocographic recordings in studied fetuses (data not shown).
6. Discussion
We found that FHRV was decreased in the fetuses with slightly elevated cord
arterial base deficit from 8 to 12 mmol /L in comparison to the fetuses with normal
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base deficit values. The results suggest that autonomic cardiac control is changed and
can be detected by spectral analysis of HRV in fetuses with risk for minor neonatal
complications. These changes are apparent before any detectable changes in the mean
HR can be noticed.
Acute short-term fetal hypoxia leads to increased FHRV in fetal lambs as shown by
Parer et al. [8]. The ability of the cardiovascular control system to increase HRV in
hypoxia is a sign of adequate fetal compensatory mechanisms. The cord arterial base
deficit suggests that the fetus has been repeatedly under stress during labor [1]. Fetal
metabolic acidemia, caused by long-term insufficiency in the placental gas exchange,
leads to decreased HRV in fetal sheep [9]. As assessed by computation the difference
between the longest and shortest R–R interval for every minute [9]. A decrease in
spectral measures of HRV has been reported to indicate and predict the severity of the
disease and injury in critically ill neonates [10–12]. Our results show that a decrease
in the oscillations of the fetal heart rate during labor is associated with an unfavorable
acid–base balance of the neonate. Interestingly, FHRV decreases in fetuses with cord
arterial base deficit values from 8 to 12 mmol /L before any detectable changes in the
mean HR. An equal cord arterial base deficit has previously been associated with
minor complications in the cardiovascular and central nervous system in newborns.
More severe increase in the cord arterial base deficit value appears to be connected to
severe neonatal complications [2].
The gestational age and, consequently, maturation of the autonomic nervous
system considerably affect the fetal hemodynamic responses to distress [13,14].
However, the gestational age was similar in both study groups. Further, external
factors such as uterine activity and maternal medication affect the fetal heart rate
[15,16]. However, in our subjects uterine contractions cannot cause periodic changes
in fetal HR because of the short signal segments. Secondly, epidural analgesia (EA)
has been reported to affect fetal HR. In this study heart rate of the fetuses whose
mothers received EA during labor did not differ from the ones without EA. The
analyzed FHR segment was rather short, because a stationary signal is required for
spectral analysis and long segments often contain global or long-term trends.
In conclusion, we found that fetuses with cord arterial base deficit between 8 to 12
mmol /L have decreased FHRV as assessed by spectral analysis although the baseline
heart rate remained unchanged. Thus, spectral analysis of FHRV may be a useful
measure to find fetuses at risk of acidosis. The observed changes may rather originate
from changed sympathetic than vagal activity, because vagal nervous system is still
rather immature in fetuses [17]. The clinical usefulness of our observations on FHRV
patterns in predicting fetal distress remains to be verified in further studies.
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Marked fetal acidosis and specific changes in power
spectrum analysis of fetal heart rate variability
recorded during the last hour of labour
Saila M. Siira,a Tiina H. Ojala,b Tero J. Vahlberg,c Jarmo O. Jalonen,a
Ilkka A. Välimäki,b Karl G. Rosén,d Eeva M. Ekholme
Objective To assess whether intrapartum acidosis affects specific components of fetal heart rate variability.
Design Prospective clinical study.
Setting Twelve Nordic delivery units.
Subjects Fetal heart rate variability was studied in 334 fetuses divided into two groups according to cord
pH value: the acidotic group (cord arterial pH <7.05 at birth, n ¼ 15) and the control group (cord arterial
pH 7.05 at birth, n ¼ 319).
Methods In spectral analysis of fetal heart rate variability, frequencies were integrated over the total
frequency band (0.04–1.0 Hz), low-frequency band (0.04–0.15 Hz) and high-frequency band (0.15–
1.0 Hz). We also calculated the low-to-high frequency ratio.
Main outcome measures The spectral bands of fetal heart rate variability were compared between the
acidotic and control fetuses.
Results We found that during the last hour of monitoring, baseline fetal heart rate gradually decreased,
whereas total, low-frequency and high-frequency fetal heart rate variability initially increased but then, near
the delivery, decreased in the acidotic fetuses when compared with the controls. Low-to-high frequency
ratio was greater in the acidotic group during the whole study period (P ¼ 0.002). Cord artery pH was
inversely associated with total fetal heart rate variability (P < 0.001), low-frequency fetal heart rate
variability (P < 0.001) and low-to-high frequency ratio (P ¼ 0.004).
Conclusions Marked fetal acidosis was associated with frequency-specific changes in fetal heart rate
variability as reflecting the compensation ability of autonomic nervous activation during the last hour of
labour.
INTRODUCTION
Early and accurate detection of fetal asphyxia is crucial
to prevent fetal morbidity, especially cerebral damage.
Cardiotocography is widely used to monitor fetal wellbeing
during delivery. However, cardiotocography has several
limitations: the positive predictive value of abnormal intra-
partum fetal heart rate patterns for fetal acidaemia is only
around 30%, and continuous cardiotocography monitoring
may increase unnecessary operative interventions.1 Also,
visual interpretation of fetal heart rate traces is subjective.
This may lead to high inter-observer variability, especially
in tracings that are not reactive, and a kappa value as low as
0.33 has been reported. However, in normal tracings, the
agreement between various analysts is better, the kappa
value being 0.86.2
Automatic computerised analysis of the fetal heart rate
pattern during labour may be a method to improve the
accuracy and consistency of detecting specific fetal heart
rate patterns. Computerised analysis of fetal heart rate
variation has been successfully applied to fetal heart rate
tracings obtained prior to the onset of labour.3 The system
is based on applying standard techniques of fetal heart rate
beat-to-beat variance measurements and does not lend itself
to continuous fetal heart rate variability assessments in a
non-stationary fetal heart rate signal (a signal that shows
linear or global trends). Unfortunately, computerised fetal
heart rate variability has not proved helpful during labour.4
However, modern signal processing techniques may be of
value in providing further information on changes in fetal
heart rate variation during labour.
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During the development of fetal hypoxia, the autonomic
nervous system becomes activated and this causes changes
in fetal heart rate control.5 This is an important sign of
adequate circulatory adaptation in a compromised fetus.
Fetal heart rate oscillates at specific frequencies, because of
the negative feedback and time-delay of the cardiovascular
control system.6 A frequency-specific assessment of fetal
heart rate by power spectral analysis may be used to
monitor non-invasively features of fetal autonomic cardiac
control.5,7,8 However, in acidotic human fetuses, the value
of spectral analysis in detecting changes in cardiac control
is still poorly known. The aim of the study was to test
whether term fetuses born with marked cord artery acid-
aemia would display differences in fetal heart rate spectral
analysis during the last hour of the recording compared
with a non-acidotic control group.
METHODS
We analysed spectral band densities of fetal heart rate
signal sets from the last hour of delivery in 356 live born
fetuses. The recordings were collected from 12 Nordic
delivery units from June 1998 to January 1999 as a part
of a Nordic observational multicentre study.9 Those eligible
for the study were women in active labour at more than
35 completed gestational weeks, and for whom a clinical
decision had been made to apply a fetal scalp electrode
for continuous internal cardiotocography recording. The
umbilical cord arterial acid–base status was analysed after
delivery. None of the fetuses had major cardiac anoma-
lies. We excluded 22 out of 356 (6%) fetuses because of
the poor quality of the electrocardiogram (ECG). The
ethics committees of the participating hospitals approved
the study and all mothers gave their informed consent.
The fetuses were divided into two groups according to
their cord arterial pH value at birth: (1) the acidotic group
had a pH <7.05 (n ¼ 15) and (2) the control group had a
pH  7.05 (n ¼ 319). The current database has been
analysed in another study regarding ST waveform changes
in fetal ECG.9 All the acidotic fetuses displayed an increase
in T/QRS ratio, with ST segment elevation on average 24
(median), 18–33 minutes (95th CI) before the end of
recording. In the present study, the median time lag bet-
ween the end of recording and delivery was 4 minutes,
1–9 minutes (95th CI) in acidotic fetuses, of whom all but
one were delivered vaginally. There was no difference in
proportion of excluded fetuses between study groups (P ¼
0.09). The clinical data of the fetuses are shown in Table 1.
The fetal ECG was recorded during delivery with an
intrauterine scalp electrode using a STANRS 21 monitor
(Neoventa Medical, Gothenburg, Sweden). The fetal uni-
polar ECG lead configuration consisted of a single-helix
scalp electrode and a maternal skin electrode. The R-peaks
were detected and R–R intervals were measured and di-
gitised at a sampling rate of 500 Hz. The R–R interval data
sets were stored on a PC hard disk and the intervals from
the last hour of delivery were analysed offline. Two-minute
continuous signal segments of stationary fetal heart rate
were required for spectral analysis. The quality of these
segments was visually controlled by our signal analyst (J.J.)
who was blinded to the grouping and clinical details of the
fetuses. On average, 10 segments (range from 1 to 29) were
obtained from each fetus. The mean time lag from the last
studied R–R interval to the end of recording and the num-
ber of ECG segments studied were similar in both groups.
However, due to the reduction in the number of 2-minute
epoques of continuous fetal heart rate signal during the
last 10 minutes of the recording, the last epoque analysed
in the acidotic group was obtained 8 minutes before the
end of recording.
The R–R interval data sets were transformed to a contin-
uous digital signal by linear interpolation, and then the event
series were resampled at the rate of 16 Hz. The reciprocal of
each R–R interval was computed to obtain the respective
instantaneous heart rate reading. Fast-Fourier-Transformed
power spectra were then computed for the fetal heart rate
signal segments (MATLABR-oriented tailor-made signal
analysis program, MARAPS, Tampere, Finland).10
Fetal heart rate variability spectrum was integrated
over the total frequency band (0.04–1.0 Hz) as well as over
the low-frequency band from 0.04 to 0.15 Hz (from 2.4 to
7.8 cycles/minute) corresponding mainly to sympathetic
and parasympathetic control, and over the high-frequency
Table 1. Clinical data of 15 acidotic and 319 control fetuses. Values are expressed as mean (range) or median [range] unless stated otherwise. P ¼ statistical
significance for difference between the study groups.
Acidotic fetuses Control fetuses P
Gestational age, weeks 40 [35 to 42] 40 [36 to 43] 0.89*
Birthweight, g 3339 (2050 to 4450) 3602 (1600 to 5630) 0.07y
No. of caesarean section (%) 1 (7) 38 (12) 1.00§
5-minute Apgar score 8 [3 to 10] 10 [5 to 10] <0.001*
Cord arterial pH 6.93 (6.75 to 7.03) 7.22 (7.05 to 7.45) <0.001y
Cord arterial base deficit, mmol/L 12.6 (7.9 to 18.0) 5.2 (3.7 to 11.3) <0.001y
* Wilcoxon two-sample test.
y Two-sample t test.
§ Fisher’s exact test.
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band from 0.15 to 1.0 Hz (from 7.8 to 60 cycles/minute)
corresponding to parasympathetic control.11 Fetal heart
rate may itself alter fetal heart rate variability. To mini-
mise such an effect, we calculated the coefficient of com-
ponent variance (square root of power spectra /mean R–R
interval).12 We also calculated the low-to-high frequency
ratio to display the balance of sympathetic and parasym-
pathetic control.11 All the spectral variability data are
given in arbitrary units (AU).
Longitudinal data of fetal heart rate and fetal heart rate
variability parameters were analysed using analysis of
variance (ANOVA) for repeated measures where grouping
factor (acidotic or control) and within factor (time of study
period) were independent variables. Because of the skewed
distribution of data, the fetal heart rate variability values
were log-transformed for repeated measures analysis (ex-
cept for fetal heart rate). If there were significant inter-
actions between the group and time of study period, the
Student’s t test was used for further analysis. The associ-
ation between fetal heart rate or fetal heart rate variability
(dependent variables) and gestational age, birthweight and
cord arterial pH value (continuous independent variables)
were analysed with the linear model for repeated measures.
Time of study period was used as repeated factor in linear
models. The clinical data were analysed with the Student’s
t test, Wilcoxon two-sample test or Fisher’s exact test, as
appropriate. The results are expressed as mean (range) or
median [range], as appropriate. P < 0.05 was considered
significant. Statistical analysis was performed with SAS
System for Windows, release 8.01 (SAS Institute, Cary,
North Carolina, USA).
RESULTS
We found that during the last hour of monitoring,
baseline fetal heart rate gradually decreased, whereas spec-
tral band densities assessing total fetal heart rate variability,
low-frequency and high-frequency fetal heart rate variabil-
ity first gradually increased but then dropped near the
delivery in the acidotic fetuses when compared with the
controls (Figs 1 and 2). Low-to-high frequency ratio was
greater in the acidotic group during the whole study period
(P ¼ 0.002, Fig. 2) due to a predominant rise in low-
frequency fetal heart rate variability.
The cord arterial pH from all fetuses was inverse-
ly associated with total fetal heart rate variability (P <
0.001), low-frequency fetal heart rate variability (P < 0.001)
and low-to-high frequency ratio (P ¼ 0.004). There was a
significant interaction between time of the study period
and cord arterial pH in high-frequency fetal heart rate
variability (P ¼ 0.007), suggesting that the association
between high-frequency fetal heart rate variability and cord
arterial pH was not the same over the last hour of the
Fig. 1. Mean fetal heart rate during the last hour of labour in the acidotic fetuses (pH < 7.05) and the control fetuses (pH  7.05). There was a significant
interaction between the study groups and time of the study period (P ¼ 0.001; ANOVA for repeated measures). Number of signal segment samples is
presented above the measuring points. * ¼ significant difference between groups (P < 0.05; two-sample t test).
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recording. High-frequency fetal heart rate variability was
positively associated with gestational age (P ¼ 0.044)
and negatively associated with birthweight (P ¼ 0.043)
in contrast to the other parameters studied showing no as-
sociations with gestational age or birthweight.
CONCLUSIONS
We found that during the last hour of delivery, fetal
heart rate gradually decreased, whereas fetal heart rate
variability initially increased but then gradually dropped
as labour progressed in acidotic fetuses. To test how
marked acidosis would influence fetal heart rate variabil-
ity, a cutoff point of cord artery pH of 7.05 was chosen.
This is a level of acidosis known to expose the fetus to
a risk of neonatal symptoms. Also, it has been applied
as a marker of significant acidosis in previous studies on
intrapartum asphyxia.9,13,14
In the human fetus, acute hypoxia causes a small increase
in fetal heart rate, but in severe acidosis fetal heart rate
gradually declines, resulting in bradycardia.15,16 The reduc-
tion in fetal heart rate variability in the presence of brady-
cardia appears to be a rather late sign of severe acidosis,5,17
and is associated with reduced cerebral oxygen consumption
and poor fetal outcome.16,18 Although there are significant
Fig. 2. Fetal heart rate variability in different spectral frequency bands during the last hour of labour in the acidotic fetuses (pH < 7.05) and the control fetuses
(pH  7.05). There was a significant interaction between the study groups and time of the study period in total fetal heart rate variability (P ¼ 0.018), low-
frequency fetal heart rate variability (P ¼ 0.03) and high-frequency fetal heart rate variability (P ¼ 0.009; ANOVA for repeated measures). The low-to-high
frequency ratio was greater in the acidotic group than in the control group (P¼ 0.002) and no significant interaction was observed. The spectral components of
fetal heart rate variability are presented in arbitrary units (AU). * ¼ significant difference between groups (P < 0.05; two-sample t test).
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non-neural influences, it appears that a large proportion of
fetal heart rate variability may be explained by centrally
mediated fluctuations in the autonomic nervous system.19
However, specific fetal heart rate patterns associated with
developing hypoxia in labour remain largely unknown.
Recently, data in a large randomised controlled trial
have shown the ability of automatic ST waveform anal-
ysis to provide a warning in situations of developing hy-
poxia and acidosis, thus substantially reducing the risk of
term neonates being affected by adverse events in labour.14
The current database have been analysed in another study
regarding ST waveform changes in fetal ECG.9 All the
acidotic fetuses displayed an increase in T/QRS ratio
coinciding in time with the increase in low-frequency
fetal heart rate variability. Such an ST pattern is associ-
ated with enhanced h-adrenoceptor activity and an adren-
aline surge.20,21
Spectral analysis provides a tool for quantifying rather
small changes in fetal heart rate variability that may remain
undetected if only visual interpretation of fetal heart rate
tracings is used. In the spectrum, we can examine the
simultaneously occurring slow and fast fetal heart rate
oscillations and estimate changes in both sympathetic and
parasympathetic control of the autonomic nervous system.
In our study, the initial increase observed in total fetal heart
rate variability was composed mainly of an increase in low-
frequency fetal heart rate variability. This is mainly due to
sympathetic activation,5 but parasympathetic activity also
contributes to increased low-frequency variation as shown
in adults.11 In fetuses, however, the sympathetic system
predominates and it is active earlier in fetal life than the
parasympathetic system becoming more prominent with
advancing maturity.22 This was further corroborated in
this study showing a positive association between high-
frequency fetal heart rate variability and the gestational
age of the fetuses studied. Finally, in the acidotic fetuses,
sympathetic predominance was also reflected in the in-
creased low-to-high frequency ratio, which is a sign of in-
creased sympathetic activation according to experimental
studies.23 On the other hand, the decrease in fetal heart
rate variability, following an initial increase, observed in
the acidotic group, may represent an initial sign of de-
compensation of the circulatory system during marked
acidosis. Probably largely depending on the diminishing
number of signal segment samples toward the end of the
delivery, the decrease in fetal heart rate variability was
significant only in total fetal heart rate variability. The
tendency was, however, seen also in low-frequency and
high-frequency fetal heart rate variability, as well as in
low-to-high frequency ratio.
Because the fetal heart rate and fetal heart rate variabil-
ity are also dependent on each other, in our study all the
fetal heart rate variability data were corrected for baseline
heart rate.12 Several additional factors such as gestational
age, fetal activity, uterine contractions and medication also
modify fetal heart rate variability. In our study, gestational
age showed no association with low-frequency or total fetal
heart rate variability probably because only pregnancies
over 35 weeks were included. Fetal movements may
increase low-frequency fetal heart rate variability, but there
have also been contradictory results.24,25 During deliv-
ery, fetal movements decrease and, when they do occur,
they are mostly associated with uterine contractions.26,27
During acidosis, the number of fetal movements further
decreases.26 Therefore, the observed increase in low-
frequency fetal heart rate is unlikely to be caused by fetal
movements. To what extent contractions per se may cause
enhanced fetal sympathetic activity is unclear.19 However,
they are unlikely to influence our results, because we studied
fetal heart rate variability in 2-minute signal segments. A
contraction should take place at least three times within a
2-minute signal segment in order to be detected by spectral
analysis. Finally, epidural or spinal analgesia may cause
minimal changes in fetal heart rate.28 These changes are,
however, transient and resolve within 30 minutes,29 and
only tracings from the last hour of delivery were included
in this study.
In conclusion, our results suggest that changes in fetal
heart rate variability as measured by spectral band densi-
ties, together with decreased fetal heart rate during the last
hour of delivery, reflect problems of autonomic cardiac
control in mature fetuses responding to the stress of labour.
The current data show feasibility of quantifying fetal heart
rate variability to assist in the interpretation of complex
fetal heart rate patterns. However, the number of acidotic
fetuses was rather small for far-reaching conclusions on
clinical applicability. Our results give an indication that
spectral analysis of fetal heart rate variability gives addi-
tional information for identification of acidotic fetuses
along with standard cardiotocography and fetal ECG.
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Objective To find whether low-to-high frequency (LF/HF) ratio
of fetal heart rate (FHR) variability changes in relation to a
significant ST-event during delivery, and if the change is predictive
of metabolic acidosis of the newborn.
Design A case–control study.
Setting Data from a multicentre project.
Subjects Acidotic and control fetuses with abnormal
cardiotocography together with a ST-event in fetal
electrocardiogram (ECG).
Methods We studied intrapartum FHR variability with spectral
analysis from 34 fetuses with a significant ST-event in the fetal
ECG. LF/HF ratio of FHR variability was measured within a
period of 1 hour before and 1 hour after a significant ST-event.
Sensitivity and specificity of the change in LF/HF ratio of FHR
variability in prediction of metabolic acidosis (pH £ 7.05 and base
deficit value > 12.0 mmol/l) of the newborn were described by
means of the receiver operating characteristic curve.
Main outcome measures Change in LF/HF ratio of FHR in
relation to a significant ST-event.
Results We found that a relative change in LF/HF ratio greater
than 30% in relation to a significant ST-event predicted cord
arterial metabolic acidosis with a sensitivity of 89% (95% CI
68–100%) and specificity of 80% (95% CI 64–96%).
Conclusions Relative changes in LF/HF ratio of FHR variability in
relation to a significant ST-event are more pronounced in fetuses
born with metabolic acidosis.
Keywords Fetal electrocardiography, fetal heart rate variability,
labour, metabolic acidosis, power spectra, ST-event.
Please cite this paper as: Siira S, Ojala T, Ekholm E, Vahlberg T, Blad S, Rosén K. Change in heart rate variability in relation to a significant ST-event associates
with newborn metabolic acidosis. BJOG 2007;114:819–823.
Introduction
Assessment of fetal wellbeing during delivery is complex.
The specificity of abnormal cardiotocography (CTG) is
low in revealing hypoxia. Thus, additional information is
needed. Oxygen deficiency may cause a rise in the ST wave-
form of the fetal electrocardiogram (ECG). This rise has
been shown to be associated with anaerobic myocardial
metabolism and related to a surge in adrenaline as part of
fetal response to hypoxia.1,2 Currently, conventional fetal
heart rate (FHR) features in conjunction with automatic
ST analysis of the fetal ECG are used to indicate abnormality.
This has been shown to reduce both the rates of operative
deliveries for fetal distress and metabolic acidosis during
birth.3,4 The cardiovascular response to hypoxia in the fetus
depends on fetal reserves and the severity of hypoxia.5
Besides hypoxia, there are physiological reasons behind an
ST rise. Arousal reactions may increase myocardial workload
and cause a rise in ST segment of fetal ECG.6 Therefore,
more detailed information on the origin of fetal reactions
may be useful.
Oxygen deficiency activates autonomic nervous system and
causes changes in FHR and FHR variability.7 Power spectral
analysis can be used to detect and quantify these changes.
Low-to-high frequency (LF/HF) ratio may serve as a FHR
variability marker to assess fetal metabolic acidosis during
delivery.8 The aim of this study was to find if fetuses with
metabolic acidosis could be identified by measuring a change
in LF/HF ratio of FHR variability at the time of a significant
ST-event in fetal ECG.





ECG recordings of 911 fetuses with cord artery acid–base status
measured after birth were collected as a part of a multicentre
project on intrapartum fetal monitoring between October 2000
and June 2002.9 Fetal ECG was recorded and analysed with
STAN software (STAN, Neoventa Medical, Moelndal, Swe-
den), which provides automatic analysis of the ST interval
of fetal ECG.3,10 Based on the STAN clinical guidelines,9 an
intermediary or abnormal CTG together with a ST change is
considered as a significant ST-event. Of all acidotic fetuses
(pH £ 7.05; n = 52) of the original data, we selected those
acidotic fetuses having a significant ST-event in fetal ECG
and more than 10 minutes good quality ECG recording both
before and after the first significant ST-event (n = 22). Meta-
bolic acidosis was defined as both a cord artery pH £ 7.05 and
a base deficit value (BDecf) > 12.0 mmol/l. A control fetus for
every acidotic fetus in the original data was chosen as the next
fetus delivered within the same labour ward with a cord arterial
pH ‡ 7.20 and BDecf < 8 mmol/l (n = 51). Of these fetuses, we
selected those control fetuses that had a significant ST-event in
fetal ECG andmore than 10minutes good quality ECG record-
ing both before and after the first significant ST-event (n = 12).
The median time lag between the first significant ST-event and
delivery was 48 minutes (range 11–536 minutes, no difference
between the study groups, P = 0.69). An ST-event was due to
an increase in T-wave amplitude (ST rise) in 31 fetuses and
due to biphasic ST segments in 3 of the 34 studied fetuses.
Selection of the studied fetuses is shown in Figure 1. None of
the fetuses had major cardiac anomalies. Clinical data of the
studied fetuses are shown in Table 1. Ethical approval and
informed consent was obtained in those centres where STAN
was not being used as part of standard care.
Data acquisition and signal processing
Fetal ECG was recorded with an intrauterine scalp electrode
using a STANS 21 monitor. Fetal unipolar ECG lead con-
figuration consisted of a single helix scalp electrode and
a maternal skin electrode. R-peaks were detected, and R-R
intervals were measured and digitised at a sampling rate of
500 Hz. The R-R interval data sets were stored digitally as part
of STAN data archiving, and the intervals from the study
period were analysed off-line.
LF/HF ratio
TheLF/HF ratio of FHRvariability11wasmeasuredwith spectral
analysis in 2-minute segments from a period of 1 hour before
and 1 hour after a significant ST-event or until delivery. On
average, 22 continuous 2-minute segments were obtained from
each fetus. The quality of these segments was checked by a signal
analyst, and data analysis was performed with no knowledge on
the clinical details of the fetuses. In the case of large signal breaks
in 2-minute R-R data segment, a new segment was started
immediately after a break. The R-R interval data sets were trans-
formed to a continuous digital signal by linear interpolation,
and the reciprocal of each R-R interval was computed to obtain
the respective instantaneous heart rate reading. Fast-Fourier-
Transformed power spectra was computed for the FHR signal
segments (MATLAB-oriented tailor-made signal analysis pro-
gram, MARAPS, Tampere, Finland).12
For calculation of LF/HF ratio of FHR variability, power
spectrum was integrated over the low-frequency band from
0.04 to 0.15 Hz (from 2.4 to 7.8 cycles/minutes) and over the
high-frequency band from 0.15 to 1.0 Hz (from 7.8 to 60
cycles/minutes). To minimise the effect of FHR to FHR var-
iability, we calculated the coefficient of component variance
(square root of power spectra/mean R-R interval).13
Statistical methods
For each fetus, a relative change in LF/HF ratio was cal-
culated ([median LF/HFafter–median LF/HFbefore]/median
LF/HFbefore) in association to a significant ST-event. The best
cutoff value to find those fetuses showing metabolic acidosis
A subgroup of fetuses (with
scalp blood sample taken)
 n = 911
Acidotic fetuses
(cord pH ≤ 7.05)
n = 52 
Control fetuses
(cord pH ≥ 7.20)
n = 51
A significant ST-
event in fetal ECG
during delivery
n = 38 
A significant ST-
event in fetal ECG
during delivery













Figure 1. Selection of the studied fetuses.
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during birth was determined by a receiver operating character-
istic (ROC) curve. The 95% CIs for sensitivity and specificity
were calculated based on the binomial proportion. Logistic
regression analysis was performed to test whether the same
cutoff value can be used for both an increase and a decrease
in LF/HF ratio. The background characteristics of the fetuses
were tested with Fisher’s exact test, Student’s t test or Wilcoxon
two-sample test, as appropriate. The results are expressed as
mean (range) ormedian [range]. P-value < 0.05 was considered
significant. Statistical analysis was performed with SAS System
for Windows, release 8.01 (SAS Institute, Cary, NC, USA).
Results
Greater than 30% change in relative LF/HF ratio of FHR vari-
ability in relation to a significant ST-event was associated with
cord arterial metabolic acidosis. The sensitivity of this change
in prediction of metabolic acidosis was 89% (95% CI 68–
100%) and specificity 80% (95% CI 64–96%) (Figure 2). Only
one of nine newborns with metabolic acidosis was not identi-
fied with this cutoff value, whereas two control cases with pH ‡
7.20 revealed marked LF/HF change. Three fetuses with greater
than 30% increase in relative LH/HF ratio that did not have
metabolic acidosis showed a low pH < 7.05 and BDecf 8.5, 10.6
and 10.9 mmol/l during birth. The relative changes in LF/HF
ratio associated to cord arterial BDecfs are shown in Figure 3.
Clinical characteristics of the fetuses are shown in Table 2.
Discussion
We found that a relative change in LF/HF ratio of FHR var-
iability greater than 30% in relation to a significant ST-event
is associated with cord artery metabolic acidosis.
Table 1. Clinical data of the studied fetuses. Values are expressed as mean (range) or median [range] unless stated otherwise. P = statistical
significance for intergroup difference
Acidotic fetuses (n 5 22) Control fetuses (n 5 12) P-value
Gestational age, weeks 40.5 [37–43] 40 [38–42] 0.91*
Birthweight, g 3576 (2545–4600) 3409 (2505–4250) 0.37**
Number of operational deliveries 14 7 1.00***
5-minute Apgar score 8 [4–10] 10 [9–10] 0.003*
Cord arterial pH 6.99 (6.89–7.04) 7.24 (7.21–7.29) ,0.0001**































Figure 2. ROC curve of the relative change in LF/HF ratio of FHR variability
in relation to a significant ST-event in prediction of cord arterial metabolic
acidosis.


























Figure 3. The relative change in spectral powers of LF/HF ratio of FHR
variability associated with a significant ST-event correlated with cord
arterial BDecfs in the studied fetuses (n = 34). Cases marked with an arrow
represent a fetus with pH £ 7.05 but BDecf < 12 mmol/l during birth.
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During delivery, making a decision to intervene is subjec-
tive and affected by several factors. The inter-observer agree-
ment has been found to be higher when CTG is interpreted
together with ST waveform analysis than alone, and interven-
tions have been shown to be more appropriate.14,15 However,
the CTG interpretation is still subjective with the risk of pat-
terns being misinterpreted.
To assess the impact of hypoxia on FHR variability and
ECG is complicated, not only from a clinical perspective
but also considering the variety in physiological responses.
Based on our current understanding, there are two key fea-
tures to be addressed: first, alterations in autonomic nervous
tone as reflected by beat-to-beat variations; and second, abil-
ity of the fetal myocardium to respond to an increase in
myocardial workload and hypoxia.
Experimental studies have shown that progressive metabolic
acidosis due to repeated umbilical cord occlusions leads to
either an increase or a decrease in FHR variability.16 It has been
previously suggested that power spectral analysis of FHR vari-
ability could be a more sensitive indicator of fetal wellbeing
than other methods based on FHR.17 Further, it has been found
that acute hypoxaemia due to umbilical artery embolism has
been associated with increased relative power (percent of total
power) in low-frequency FHR variability and decreased relative
power in high-frequency range in fetal sheep,18 thus leading to
an increased LF/HF ratio. We have previously shown that in
human fetuses the LF/HF ratio of FHR variability is superior to
other spectral measures in detection of fetal metabolic acidosis
during the last hour of labour.8
Metabolic changes in the heart muscle are reflected as ST
changes in fetal ECG.1,19 As observed in this study, ST changes
may also be seen in nonhypoxic fetuses as a consequence of
arousal reactions.4,14 According to the study protocol, all the
fetuses had a significant ST-event during delivery, but only 9
of 34 (26%) had metabolic acidosis during birth. In case there
was a significant change in the LF/HF ratio of FHR variability
together with a significant ST-event, 62% of the fetuses had
metabolic acidosis (pH £ 7.05 and BDecf > 12.0 mmol/l) and
85% had cord arterial pH £ 7.05 during birth. Therefore,
spectral analysis of FHR variability may provide clinically
relevant information of fetal wellbeing and may help differ-
entiate between physiologic ST changes from hypoxic ST
changes. In clinical situations, the sensitivity of this method
needs to be tested.
From the methodological point of view, spectral analysis of
FHR variability during labour requires a stationary signal, and
for calculation of low-frequency variability, a continuous sig-
nal segment of at least 75 seconds is needed. This is a short-
coming also in this data, because during delivery, the FHR is
often nonstationary with large fluctuations due to uterine and
fetal activity. An advantage is that R-R interval data are freely
available for spectral calculations whenever fetal ECG is
recorded.
In conclusion, this study suggests that a relative change in
LF/HF ratio greater than 30% in association with a significant
ST-event in fetal ECG predicts cord arterial metabolic acidosis
and assists in separating hypoxic ST events from physiological
arousal reactions. This additional information on fetal well-
being may help prevent unnecessary operational deliveries.
Further studies on this method in a larger material would
be of interest.
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Number of operational deliveries 10 11 0.28***
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Abstract 
Objective: To establish the association between fetal scalp blood sample (FBS) pH-value and spectral 
powers of intrapartum fetal heart rate (FHR) variability. 
Design: Retrospective observational clinical study 
Setting: Data from an EU multicenter project 
Population: 462 fetuses who had a normal pH-value (pH >7.20; controls) in scalp blood sample and 
81 fetuses who had a low scalp pH-value (≤ 7.20; low-FBSpH -fetuses). The low-FBSpH-fetuses were 
further divided into two subgroups according to the degree of acidemia: fetuses with FBS pH 7.11–
7.20 (n = 58) and fetuses with FBS pH ≤ 7.10 (n = 23) 
Methods: FHR variability was measured with power spectral analysis from a period of 14 minutes 
preceding last FBS. In addition two groups with two measure points were chosen: in the first group 
(108 fetuses), both the first and the last FBS pH were normal, and in the second group (40 fetuses) the 
initial FBS pH was or the 30 min CTG segment at the beginning of the recording was normal but the 
last FBS pH-value was low (pH ≤ 7.20).  
Main outcome measures: Changes in spectral powers in the course of labor. FHR variability in 
relation to concomitant FBS pH-value.  
Results: In the course of labor, spectral powers of FHR variability increased in all fetuses, but fetuses 
with FBS pH ≤ 7.20 had more increased spectral powers of FHR variability compared with controls 
(2.49 AU vs. 2.23 AU; p = 0.038). Further, the overall FHR variability was higher in low-FBSpH -
fetuses when compared with control fetuses. Interestingly, the fetuses with the lowest FBS pH (≤ 
7.10) had significantly lower spectral powers when compared to fetuses with FBS in the pH-range 
7.11-7.20 (1.42 AU vs. 1.59 AU; p = 0.047). There was no clinically relevant correlation between 
spectral powers of FHR variability and FBS pH-values. 
Conclusions: This study shows that intrapartum spectral powers of FHR variability are altered 
during delivery, and especially with developing fetal acidosis. Further, decreasing spectral powers of 






Detection of fetal asphyxia during labor 
and delivery is challenging. A normal and 
reactive cardiotocograph (CTG) is 
reassuring, indicating no obvious danger 
of asphyxia. Unfortunately, CTG is 
unspecific, with a great number of false 
positive findings leading to increased 
numbers of unnecessary operational 
deliveries (1).  
Fetal scalp pH aids in the identification 
of intrapartum fetal hypoxia. CTG can be 
used for screening tool; FBS is taken under 
certain conditions when the CTG is non-
reassuring (2). FBS gives only momentary 
information of fetal wellbeing (concerning 
oxygenation), and needs often to be taken 
repeatedly.  FBS is time-consuming and 
inconvenient to the parturient and may 
lead to complications. The incidence of 
complications ranges from 0.4 to 6 %. Most 
complications due to FBS are insignificant, 
although exceptional cases of neonatal 
death due to bleeding from the incision 
wound have been reported (3,4) ST 
analysis of the fetal electrocardiogram 
(ECG) is used in combination with CTG to 
assess fetal well-being during delivery. 
Compared to FBS, ST-analysis (STAN®) 
yields continuous information and is more 
convenient for the parturient. However, 
the STAN® methodology is dependent on 
interpretation of the CTG, which has high 
inter- and intraobserver variability, 
especially on nonreassuring FHR tracings 
(5). Thus, more objective information on 
specific FHR parameters would be 
advantageous, and would facilitate the 
interpretation of fetal responses to 
hypoxia. 
 In late pregnancy, the fetal autonomic 
nervous system responds to acute hypoxia 
by modulating beat-to-beat FHR changes. 
Visual FHR variability pattern recognition 
and clinical interpretation are mostly 
subjective. Heart rate fluctuations (5-25 
bpm) around baseline FHR, known as 
FHR variability, indicate normal fetal 
reactivity (6). Short-term, beat-to-beat FHR 
variations remain undetected. Power 
spectral analysis of FHR variability is an 
objective method to quantify small, 
visually undetectable changes in FHR 
variability that are under autonomic 
cardiac control (7,8). Previous studies have 
shown that low-frequency (LF) spectral 
power corresponding to parasympathetic 
and sympathetic activity, and high-
frequency (HF) spectral power 
corresponding to parasympathetic 
activity, change markedly in fetuses with 
birth acidemia (9,10). Further, a change in 
the low-to-high frequency ratio (LF/HF) 
of FHR variability in relation to a STAN 
alarm predicts fetal metabolic acidemia at 
birth (11). 
Previous studies on intrapartum FHR 
variability measured with power spectral 
analysis have mainly assessed changes of 
FHR variability in relation to cord acid 
base values measured after birth. The aim 
of the present study was to investigate the 
effect of intrapartum hypoxia and 
acidemia on FHR variability. The 
correlation between spectral powers and 
the concomitant FBS pH-value was 
calculated to examine how FHR variability 
associates with fetal intrapartum pH-
values. Further, the change in spectral 
powers of FHR variability during labor 
was assessed in fetuses with repeatedly 
normal FBS pH-values, and in fetuses with 
a low last FBS pH-value. 
 
Materials and methods 
The original data consisted of 812 fetuses 
with intrapartum ECG (R-R interval data) 
recorded as a part of an EU multicenter 
project on intrapartum fetal monitoring 
with STAN® method (12). From these data, 
those fetuses (n=543) having good quality 





minutes prior to last FBS with no cardiac 
or major extra-cardiac malformation were 
included. Duration of pregnancies 
exceeded 36 weeks. Ethical approval and 
informed consent were obtained in those 
centers where STAN® was not being used 
as part of standard care. 
FHR variability data was divided 
according to the scalp blood pH-value: 
FBS pH ≤ 7.20 is regarded as a sign of 
increased risk of fetal acidosis (13), and 
was thereby selected as a cut-off value.  
Study data was comprised of 462 fetuses 
with scalp pH >7.20 (controls) and 81 
fetuses with scalp pH ≤ 7.20 (low-FBSpH -
fetuses). The low-FBSpH -fetuses were 
further divided into two subgroups based 
on how low the FBS pH was: fetuses with 
FBS pH 7.11-7.20 (n= 58) and fetuses with 
FBS pH ≤ 7.10 (n=23). A flow chart on the 
process of selection of cases is presented in 
Fig.1. 
We also studied how FHR variability 
changes during labor and delivery in two 
additional groups with two measure 
points during delivery: in the first group 
(108 fetuses), both the first and the last FBS 
pH were normal, and in the second group 
(40 fetuses) the initial FBS pH was or the 
30 min CTG segment at the beginning of 
the recording was normal but the last-FBS 
pH-value was low (pH ≤ 7.20).(the interval 
between the end of normal CTG segment 
and last FBS was over 75 minutes).  
Data acquisition and signal processing. 
Fetal ECG was recorded during delivery 
with an intrauterine scalp electrode using 
a STANS 21 monitor (Neoventa Medical, 
Moelndal, Sweden). Fetal unipolar ECG 
lead configuration consisted of a single-
helix scalp electrode and a maternal skin 
electrode. R-peaks were detected, and R-R 
intervals were measured and digitized at a 
sampling rate of 500 Hz. The R-R interval 
data sets were stored digitally as part of 
STAN data archiving, and the intervals 
from the study period were analyzed off-
line.  
Spectral analysis. FHR variability was 
quantified with spectral analysis as 
previously described (9,11,14). Power 
spectral analysis was performed in 2-
minute signal segments from a period of 
14 minutes (7x2min) preceding the FBS. 
On average, four continuous 2-minute 
signal segments were obtained, and mean 
spectral power of these segments was 
calculated.  The quality of these signal 
segments was checked by a signal analyst, 
and data analysis was performed with no 
knowledge on the clinical data. In the case 
of large signal breaks in the 2-minute R-R 
data segments, a new segment was started 
immediately after a break to minimize loss 
of data. The R-R interval data sets were 
transformed to a continuous digital signal 
by linear interpolation, and then the event 
series was resampled at the rate of 16 Hz. 
The reciprocal of each R-R interval was 
computed to obtain the respective 
instantaneous heart-rate reading. Fast-
Fourier-Transformed power spectra were 
then computed for the FHR signal 
segments (MATLAB®-oriented tailor-
made signal-analysis program, MARAPS, 
Tampere, Finland) (15) . 
The FHR variability spectrum in a 2-
minute R-R data segment was integrated 
over the total frequency band (0.04 – 1.0 
Hz), as well as over the low-frequency 
(LF) band from 0.04 Hz to 0.15 Hz (from 
2.4 to 7.8 cycles / min) (corresponding 
mainly to sympathetic and para-
sympathetic control), and over the high-
frequency (HF) band from 0.15 Hz to 1.0 
Hz (from 7.8 to 60 cycles / min) 
(corresponding to parasympathetic 
control) (16).  To minimize the effect of 
FHR on FHR variability, we calculated the 
coefficient of component variance (square 





(17). Low-to-high frequency ratio (LF/HF) 
was assessed to display the balance of 
sympathetic and parasympathetic control 
(16). All the spectral variability data are 
given in arbitrary units (AU). 
Statistical methods. The results were 
statistically analyzed by SAS System for 
Windows, release 8.01 (SAS Institute, 
Cary, North Carolina, USA).  The 
continuous variables in the clinical data 
were analyzed with a Student's two-
sample test or a Wilcoxon two-sample test, 
as appropriate. The proportion of 
operative deliveries between groups was 
compared with a chi-square test. Because 
of a skewed distribution of data, FHR 
variability values were square-root-
transformed. The results are expressed as 
mean (range), median [range] or number 
(percentage %), as appropriate. The 
associations between spectral bands and 
FBS pH were analyzed with the Spearman 
correlation coefficient. Because gestational 
age is known to affect FHR variability (18) 
(19), the partial correlation coefficient 
between spectral bands and the FBS pH 
was also calculated by adjusting 
correlation for gestational age as a 
covariate. The differences of spectral 
bands between subgroups were tested 
with the T-test. P –value <0 .05 was 
considered significant.  
 
Results 
Clinical data from the studied fetuses are 
presented in Table 1.  Low-FBSpH -fetuses 
revealed, as expected, more operative 
deliveries, and had shorter time lag from 
FBS to birth.  
Fetuses developing intrapartum 
acidemia (normal first scalp pH-value, or 
normal CTG, with last scalp pH-value ≤ 
7.20) had a more pronounced increase in 
the spectral powers of FHR variability 
from the first to second measure points 
when compared to fetuses with repeatedly 
normal scalp pH (>7.20) (p=0.0005; Fig.2).  
Overall FHR variability was higher in 
low-FBSpH -fetuses when compared with 
control fetuses (p=0.038; Fig. 3). However, 
the subgroup of most-affected fetuses 
(those with FBS pH ≤ 7.10) had 
significantly lower FHR variability 
spectral powers when compared to fetuses 
with FBS pH 7.11-7.20 (p=0.047; Fig. 3). No 
differences in LF/HF ratio were found 
between the study groups (data not 
shown).  
In low-FBSpH -fetuses, overall spectral 
powers of FHR variability had weak 
positive correlation with FBS pH (total 
power; r = 0.29, p=0.008), whereas the 
correlation was poor and negative in 
fetuses with FBS >7.20 (total power; r = - 
0.15, p=0.001). In these groups, LF and HF 
spectral powers did not correlate any 
better with FBS pH. However, in fetuses 
with FBS pH ≤ 7.10 HF, spectral powers of 
FHR variability correlated (r=0.498; 
p=0.018) with FBS pH. Adjusting 
correlations for gestational age had no 
effect on the results (data not shown). 
 
Discussion  
This study shows that in the course of 
delivery, spectral powers increased both 
in fetuses with constantly normal FBS and 
in low-FBSpH -fetuses. However, the 
increase was more pronounced in low-
FBSpH -fetuses. This finding is in 
accordance with previous ones (20) 
confirming that fetuses react to normal 
labor stress by increasing heart rate 
variability. However, fetuses forced to 
adapt to increasing demands during 
delivery seem to react more intensively. 
 Spectral powers of FHR variability 
were higher in low-FBSpH -fetuses 





intrapartum hypoxia. However, in the 
subgroup of most-affected fetuses (FBS pH 
≤ 7.10), FHR variability was the lowest. 
Furthermore, FHR variability correlated 
positively with fetal scalp pH in low-
FBSpH -fetuses. This suggests that vagal 
control diminishes with decreasing pH.  
Our results from a large number of 
deliveries are in agreement with 
experimental studies, suggesting that in 
the acute phase of hypoxia without 
acidemia, the autonomic nervous system 
is activated, and FHR variability is 
increased (21). As oxygen deficiency 
prolongs and hypoxia deepens, FHR 
variability starts to decrease (22).  There 
are only few clinical studies published on 
the association of FHR variability as 
assessed with spectral analysis and birth 
acidosis (9-11,14,23). All these studies 
show that fetal acidemia alters FHR 
variability, but detailed comparison of the 
results is difficult because of 
methodological differences. We have 
previously shown that total, LF and HF 
FHR variability initially increase, but 
when approaching delivery, decrease in 
those fetuses with cord-artery acidosis 
when compared with fetuses with normal 
cord-artery pH (9). 
The association of FBS pH with FHR 
variability is largely unknown. Van Laar 
et al (24) have previously investigated, in a 
small population, the relation of fetal scalp 
pH to FHR variability. They found no 
association of LF (0.04-0.15 Hz) or HF (0.4-
1.5 Hz) powers with FBS pH. They also 
calculated normalized LF (LF divided by 
total power) and normalized HF powers 
of FHR variability that were associated 
with FBS pH. It is notable that their 
spectral bands were different from ours, 
and the number of fetuses in their study 
was too small to enable clinical 
conclusions.  We found that in low-FBSpH 
-fetuses all spectral powers of FHR 
variability decreased with decreasing fetal 
scalp pH.  However, the variance in FHR 
variability is large.  This large variance 
during labor is likely to illustrate dynamic 
alterations in autonomic nervous system 
function. Large variation in FHR 
variability identifies a fetus capable of 
responding actively to the stress of labor 
and delivery, even with development of 
acidemia. This large variation of FHR 
variability is challenging in the context of 
clinical application, and no cut-off values 
for clinical action can be established; 
spectral analysis of FHR variability may 
thus be used in a similar fashion to ST 
analysis -with continuous assessment of 
intraindividual change in the spectral 
powers of FHR variability. 
The crucial marker for worsening fetal 
hypoxia is decreased FHR variability, 
possibly reflecting decreasing autonomic 
nervous compensation capacity (25). In 
our study, low-FBSpH -fetuses showed a 
decrease in all spectral bands of FHR 
variability as FBS pH decreased. 
Furthermore, the lowest FHR variability 
was detected in fetuses with FBS pH ≤ 
7.10. This association of spectral bands and 
FBS pH was most pronounced in HF 
powers in fetuses with the most marked 
acidemia suggesting a decrease in vagal 
activity.  Decreased fetal breathing activity 
due to hypoxia could also lead to 
decreased FHR variability, although 
intrapartum fetal breathing is rare and 
further diminished by hypoxia (26). 
Decreased FHR variability near delivery 
may thus be a sign of an alteration in the 
pattern of fetal reactions to oxygen 
deficiency (27). 
From the methodological point of view, 
FHR variability data is easily and 
continuously obtained simultaneously 
with the fetal ECG during delivery.  
Therefore, possible changes can be 





analysis of FHR variability requires a 
stationary signal, and for calculation of LF 
variability, a continuous signal segment of 
at least 75 seconds is needed (28). This is a 
shortcoming in the current data, because 
during delivery, the FHR is often non-
stationary, with large fluctuations due to 
uterine and fetal activity. We studied FHR 
variability in 2-minute signal segments, 
thus contractions are unlikely to 
contribute to our results, as they should 
take place at least three times within a 2-
minute signal segment in order to be 
detected by spectral analysis. The 
standard deviation of each spectral band 
was quite wide, reflecting dynamic 
features of FHR variability and suggesting 
that fetal state interacts with FHR 
variability changes (9,21).  
Could spectral analysis of FHR 
variability be used in clinical practice?  
Because of large individual variation in 
the spectral powers of FHR variability, a 
single measure cannot be used to 
determine fetal well-being. The results in 
this study show that FHR variability 
changes in line with fetal acid-base 
balance.  Therefore, a possibly useful 
application of FHR variability analysis 
could be a follow-up of changes in FHR 
variability during delivery.  Moreover, 
assessment of spectral analysis of FHR 
variability may complement other 
methods of assessing fetal well-being 
during delivery. 
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Table 1. Clinical data of the studied fetuses. Values are expressed as mean (range), median 








Gestational age, weeks 40 [36-42] 40 [36-43] (n=461) .6* 
Birthweight, g 3348 (1850-4350) 3468 (1940-5160) (n=461) .07** 
Operational deliveries, n (%) 73 (90 %) 253 (55 %) <.0001*** 
FBS pH 7.14 (6.93-7.20) 7.31 (7.21-7.55) <.0001** 
Cord arterial pH 7.13 (6.89-7.4) (n=75) 7.21 (6.94-7.43) (n=428) <.0001** 
5-minute Apgar score 9[1-10] 10 [3-10] <.0001* 
Timelag from FBS to birth, min 21 [4-142] 84 [5-944] <.0001* 
* Wilcoxon two-sample test 
** Two-sample t test 






Figure 1. A flow chart on the process of selection of the studied fetuses. ECG = 
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Figure 2. Change in the spectral powers of fetal heart rate (FHR) variability in the course of 
delivery in control fetuses with stable FBS pH > 7.20 vs. fetuses with developing hypoxia 
with low FBS pH (≤ 7.20).  
Spectral powers of FHR variability are measured before normal first FBS pH or during 
normal CTG (baseline), and before last FBS pH (last FBS). The spectral power of FHR 

































Figure 3. Total, low-frequency (LF) and high-frequency (HF) spectral powers of fetal heart 
rate (FHR) variability in control fetuses (fetal scalp blood sample (FBS) pH > 7.20) and in 
low-FBSpH-fetuses (FBS pH ≤ 7.20). Also, the subgroups with FBS pH 7.11-7.20 and FBS 
pH ≤ 7.10 are presented separately.  p-values are presented between the controls and low-
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